{"content":"<li class=\"n-box-item date-title\" data-end=\"1549947599\" data-start=\"1549861200\" data-txt=\"Monday, December 23, 2019\">Monday, February 11, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3431937\" data-ts=\"1549929560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTGR\" target=\"_blank\">NTGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431937-netgear-dips-3_2-after-amazon-announces-eero-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netgear dips 3.2% after Amazon announces eero deal</a></h4><ul>   <li>Amazon.com's plan to <a href=\"https://seekingalpha.com/news/3431909-amazon-com-acquiring-home-wi-fi-company-eero\" target=\"_blank\">purchase mesh networking maker eero</a> is having an effect on at least one of eero's rivals.</li>    <li>Netgear (NASDAQ:<a href='https://seekingalpha.com/symbol/NTGR' title='NETGEAR, Inc.'>NTGR</a>), maker of the similarly well known Orbi equipment, is <font color=\"red\">down 3.2%</font> after hours.</li>    <li>Other makers of mesh equipment have more diverse product bases and less exposure to Amazon competition in that area.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431937\" data-linked=\"Netgear dips 3.2% after Amazon announces eero deal\" data-tweet=\"$NTGR - Netgear dips 3.2% after Amazon announces eero deal https://seekingalpha.com/news/3431937-netgear-dips-3_2-after-amazon-announces-eero-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3431937-netgear-dips-3_2-after-amazon-announces-eero-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431934\" data-ts=\"1549928567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKTR\" target=\"_blank\">NKTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431934-nektarminus-5_9-reports-urothelial-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nektar -5.9% as it reports urothelial cancer study</a></h4><ul>   <li>Nektar Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a>) is <font color=\"red\">5.9% lower</font> postmarket after it reported a response rate of 48% in its study of treatment for urothelial cancer.</li>    <li>That rate means 11 of 23 patients enrolled in a study examining treatment of an NKTR-214 and Opdivo combination were evaluable for efficacy, vs. a previous 60% response rate in June. (h/t Bloomberg)</li>    <li>The company is <a href=\"https://seekingalpha.com/pr/17408540-nektar-therapeutics-webcast-conference-call-urothelial-cancer-specialist-analysts-and\" target=\"_blank\">presenting the results Friday</a> during the American Society of Clinical Oncology Genitourinary Cancers Symposium.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431934\" data-linked=\"Nektar -5.9% as it reports urothelial cancer study\" data-tweet=\"$NKTR - Nektar -5.9% as it reports urothelial cancer study https://seekingalpha.com/news/3431934-nektarminus-5_9-reports-urothelial-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3431934-nektarminus-5_9-reports-urothelial-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431932\" data-ts=\"1549927626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EA\" target=\"_blank\">EA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431932-eaplus-6_2-apex-legends-crosses-25m-player-mark\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EA +6.2% as &#39;Apex Legends&#39; crosses 25M-player mark</a></h4><ul>   <li>Electronic Arts (NASDAQ:<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a>) is capping quite a day for the stock with news that its new battle-royale title <i>Apex Legends</i> has <a href=\"https://www.ea.com/news/apex-legends-25-million-players\" target=\"_blank\">surpassed 25M players</a> in its first week and that it crested 2M concurrent players over the weekend.</li>    <li>Shares are <font color=\"green\">up 6.2%</font> after hours; they opened strong and were <font color=\"green\">up as much as 9.6%</font> early in the wake of an <a href=\"https://seekingalpha.com/news/3431591-bofaml-upgrades-ea-apex-potential\" target=\"_blank\">upgrade from BofA Merrill Lynch</a>.</li>    <li>But those gains tailed off during the market day before the stock closed <font color=\"red\">down 0.4%</font>.</li>    <li>EA's Respawn studio says it will kick off the game's Season One in March, debuting a Battle Pass and new in-game items.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431932\" data-linked=\"EA +6.2% as &#39;Apex Legends&#39; crosses 25M-player mark\" data-tweet=\"$EA - EA +6.2% as &#39;Apex Legends&#39; crosses 25M-player mark https://seekingalpha.com/news/3431932-eaplus-6_2-apex-legends-crosses-25m-player-mark?source=tweet\" data-url=\"https://seekingalpha.com/news/3431932-eaplus-6_2-apex-legends-crosses-25m-player-mark\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431928\" data-ts=\"1549925622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VKTX\" target=\"_blank\">VKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431928-viking-therapeutics-madrigal-move-up-gilead-liver-drug-fails-to-meet-goals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viking Therapeutics, Madrigal move up as Gilead liver drug fails to meet goals</a></h4><ul><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a>) <font color=\"green\">+8.4%</font> and Madrigal Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a>)Â <font color=\"green\">+3.3%</font> after-hours as Gilead\u2019s (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) study designed to evaluate a chronic liver disease drug <a href=\"https://seekingalpha.com/pr/17408459-gilead-announces-topline-data-phase-3-stellarminus-4-study-selonsertib-compensated-cirrhosis\" target=\"_blank\">failed to meet its primary endpoint</a>; GILD <font color=\"red\">-3.6%</font>.</li><li>GILD says its STELLAR-4 Phase 3 study designed to evaluate its selonsertib drug in patients with compensated cirrhosis due to nonalcoholic steatohepatitis did not meet its desired outcome without worsening the patients' condition.</li><li>Other companies developing therapies in liver disease include <a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a>, <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a>, <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>, <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a>, <a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>, <a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>, <a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit'>OTCPK:GNFTF</a>, <a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431928\" data-linked=\"Viking Therapeutics, Madrigal move up as Gilead liver drug fails to meet goals\" data-tweet=\"$VKTX $MDGL $GILD - Viking Therapeutics, Madrigal move up as Gilead liver drug fails to meet goals https://seekingalpha.com/news/3431928-viking-therapeutics-madrigal-move-up-gilead-liver-drug-fails-to-meet-goals?source=tweet\" data-url=\"https://seekingalpha.com/news/3431928-viking-therapeutics-madrigal-move-up-gilead-liver-drug-fails-to-meet-goals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431923\" data-ts=\"1549924395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCI\" target=\"_blank\">LCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431923-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/RLGT' title='Radiant Logistics, Inc.'>RLGT</a>Â <font color=\"green\">+12.5%</font>. <a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a>Â <font color=\"green\">+9.6%</font>. <a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>Â <font color=\"green\">+8.3%</font>. <a href='https://seekingalpha.com/symbol/MIME' title='Mimecast'>MIME</a>Â <font color=\"green\">+6.3%</font>. <a href='https://seekingalpha.com/symbol/SBLK' title='Star Bulk Carriers Corp.'>SBLK</a>Â <font color=\"green\">+5.0%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a>Â <font color=\"red\">-19.5%</font>. <a href='https://seekingalpha.com/symbol/CMP' title='Compass Minerals International, Inc.'>CMP</a>Â <font color=\"red\">-8.8%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>Â <font color=\"red\">-7.0%</font>. <a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a>Â <font color=\"red\">-5.6%</font>. <a href='https://seekingalpha.com/symbol/MITT' title='AG Mortgage Investment Trust, Inc.'>MITT</a>Â <font color=\"red\">-3.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431923\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$LCI $RLGT $CHGG - After Hours Gainers / Losers https://seekingalpha.com/news/3431923-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431923-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431920\" data-ts=\"1549924203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMP\" target=\"_blank\">CMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431920-compass-mineralsminus-9-following-big-q4-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compass Minerals -9% following big Q4 earnings miss</a></h4><ul><li>Compass Minerals (NYSE:<a href='https://seekingalpha.com/symbol/CMP' title='Compass Minerals International, Inc.'>CMP</a>) <font color=\"red\">-8.8%</font> after-hours as <a href=\"https://seekingalpha.com/news/3431853-compass-minerals-misses-0_31-misses-revenue\" target=\"_blank\">Q4 earnings</a> and revenues come in well below expectations, as Q4 and full-year operating earnings fell 15% and 18%,       respectively, from 2017 results.</li><li>Q4 Salt segment revenue rose 9% Y/Y to $284M but segment operating earnings fell 4%, as increased salt costs and lower       sales volumes more than offset the benefit of increased pricing.</li><li>CMP says it expects Q1 earnings in its Salt segment to be limited by a Y/Y  decline in North American highway deicing commitment volumes and  continued cost pressures; combined with negative foreign exchange  impacts on translated results for the Plant Nutrition South America  segment, CMP expects Q1 consolidated EBITDA of $40M-$50M.</li><li>CMP forecasts FY 2019 EBITDA of $310M-$350M; the company says it will no longer provide EPS guidance ranges after determining that full-year EBITDA guidance \"is the most relevant earnings metric to provide as it aligns more closely with how the company manages its businesses.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3431920\" data-linked=\"Compass Minerals -9% following big Q4 earnings miss\" data-tweet=\"$CMP - Compass Minerals -9% following big Q4 earnings miss https://seekingalpha.com/news/3431920-compass-mineralsminus-9-following-big-q4-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3431920-compass-mineralsminus-9-following-big-q4-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431914\" data-ts=\"1549923288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHI\" target=\"_blank\">OHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431914-omega-healthcare-2019-ffo-midpoint-trails-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omega Healthcare 2019 FFO midpoint trails consensus</a></h4><ul><li>Omega Healthcare Investors (NYSE:<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a>)<font color=\"red\"> falls 3.2%</font>Â in after-hours trading after introducingÂ <a href=\"https://seekingalpha.com/pr/17408503-omega-announces-fourth-quarter-2018-financial-results\" target=\"_blank\">Â 2019 adjusted FFO per share guidanceÂ </a>of $3.00-$3.12.</li><li>Guidance midpoint of $3.06 trailsÂ compares with consensus of $3.08.</li><li>Guidance assumes MedEquities acquisition occurs in Q2.</li><li>Also reflects revenue reduction related to Q4 asset sales and a 2019 six-month forbearance period when it will receive reduced rental payments from Daybreak, one of its operators.</li><li>Q4 adjusted FFO per share of 73 cents, missing consensus estimate by a penny; compares with 79 cents in the year-ago quarter.</li><li>Q4 total operating revenue $219.8M vs. $221.2M a year ago.</li><li>Challenges in the quarter included higher than normal G&amp;A expenses, primarily related to Orianna legal expenses, and underpayment of about $4M of rent by Daybreak.</li><li><a href=\"https://seekingalpha.com/pr/17408503-omega-announces-fourth-quarter-2018-financial-results\" target=\"_blank\">Conference call</a> on Feb. 12 at 10:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431903-omega-healthcare-investors-misses-0_15-beats-revenue\" target=\"_blank\">Omega Healthcare Investors misses by $0.15, beats on revenue</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431914\" data-linked=\"Omega Healthcare 2019 FFO midpoint trails consensus\" data-tweet=\"$OHI - Omega Healthcare 2019 FFO midpoint trails consensus https://seekingalpha.com/news/3431914-omega-healthcare-2019-ffo-midpoint-trails-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3431914-omega-healthcare-2019-ffo-midpoint-trails-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431912\" data-ts=\"1549923083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMC\" target=\"_blank\">FMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431912-fmc-corp-sees-flat-q1-ebitda-earnings-low-end-of-guidance-range\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FMC Corp. sees flat Q1 EBITDA, earnings at low end of guidance range</a></h4><ul><li>FMCÂ Corp. (NYSE:<a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a>) <font color=\"red\">-1.7%</font> after-hours as it reports better than expected <a href=\"https://seekingalpha.com/news/3431873-fmc-beats-0_21-beats-revenue\" target=\"_blank\">Q4 earnings</a> and a 24% Y/Y revenue increase but issues Q1 earnings guidance at the low end ofÂ Wall Street consensus.</li><li>For Q1, FMC forecasts EPS of $1.58-$1.68 vs. $1.67 analyst consensus estimate on revenues of $1.18B-$1.21B vs. $1.15B consensus; the company offers in-line guidance for FY 2019, seeing EPS of $5.55-$5.75, up 8% at the midpoint vs. recast 2018 earnings and in line with $5.68 consensus, and revenues of $4.45B-$4.55B vs. $4.48B consensus.</li><li>FMC says it agricultural solutions unit reported Q4 revenue ofÂ  ~$1.1B, up 18 Y/Y on a pro forma basis, with strong demand across all regions and higher prices in Brazil.</li><li>FMC says it expects \"a disproportionate amount of the full-year impact from higher raw  material costs and currency headwinds\" during H1 2019, leading to flat Y/Y adjusted EBITDA in Q1, but it is \"highly confident that we will recover all the raw material increase and a significant amount of the FX impact via price increases in all regions over the full year.\"</li><li>The company says it is set to spin off its remaining Livent (NYSE:<a href='https://seekingalpha.com/symbol/LTHM' title='Livent'>LTHM</a>) stake on March 1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431912\" data-linked=\"FMC Corp. sees flat Q1 EBITDA, earnings at low end of guidance range\" data-tweet=\"$FMC $LTHM - FMC Corp. sees flat Q1 EBITDA, earnings at low end of guidance range https://seekingalpha.com/news/3431912-fmc-corp-sees-flat-q1-ebitda-earnings-low-end-of-guidance-range?source=tweet\" data-url=\"https://seekingalpha.com/news/3431912-fmc-corp-sees-flat-q1-ebitda-earnings-low-end-of-guidance-range\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431904\" data-ts=\"1549922457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431904-gileads-selonsertib-flunks-late-stage-nash-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead&#39;s selonsertib flunks late-stage NASH study</a></h4><ul><li>Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) is holding steady after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17408459-gilead-announces-topline-data-phase-3-stellarminus-4-study-selonsertib-compensated-cirrhosis\" target=\"_blank\">announcement </a>that its Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03053063?cond=NASH+-+Nonalcoholic+Steatohepatitis&amp;lead=gilead&amp;phase=2&amp;rank=2\" target=\"_blank\">STELLAR-4</a>, evaluating selonsertib in NASH patients with compensated cirrhosis failed to sufficiently separate from placebo.</li><li>The study failed to meet the primary endpoint of the proportion of participants achieving at least a one-stage improvement in NASH classification after 48 weeks of treatment. Specifically, 14.4% of patients receiving 18 mg of selonsertib and 12.5% of those receiving 6 mg achieved at least a one-stage improvement in NASH compared to 12.8% for placebo.</li><li>On the plus side, selonsertib was generally safe and well-tolerated.</li><li>Topline results from the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03053050?cond=NASH+-+Nonalcoholic+Steatohepatitis&amp;lead=gilead&amp;phase=2&amp;rank=1\" target=\"_blank\">STELLAR-3</a> study in NASH patients with bridging fibrosis and the Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02781584?cond=NASH+-+Nonalcoholic+Steatohepatitis&amp;lead=gilead&amp;phase=1&amp;rank=3\" target=\"_blank\">ATLAS </a>trial in NASH patients with advanced fibrosis should be available later this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431904\" data-linked=\"Gilead&#39;s selonsertib flunks late-stage NASH study\" data-tweet=\"$GILD - Gilead&#39;s selonsertib flunks late-stage NASH study https://seekingalpha.com/news/3431904-gileads-selonsertib-flunks-late-stage-nash-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3431904-gileads-selonsertib-flunks-late-stage-nash-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431894\" data-ts=\"1549921496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431894-bristow-group-reports-preliminary-q3-results-beats-0_51-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow Group reports preliminary Q3 results; beats by $0.51, misses on revenue</a></h4><ul><li>Bristow (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>): Q3 Non-GAAP EPS of -$0.57 beats by $0.51; GAAP EPS of -$2.40 misses by $2.07.</li><li>Revenue of $317.09M (-8.2% Y/Y) <font color=\"red\">misses by $8.25M</font>.</li><li>Shares <font color=\"green\">+7.84%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17408485-bristow-group-reports-preliminary-third-quarter-fiscal-year-2019-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3431894\" data-linked=\"Bristow Group reports preliminary Q3 results; beats by $0.51, misses on revenue\" data-tweet=\"$BRS - Bristow Group reports preliminary Q3 results; beats by $0.51, misses on revenue https://seekingalpha.com/news/3431894-bristow-group-reports-preliminary-q3-results-beats-0_51-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3431894-bristow-group-reports-preliminary-q3-results-beats-0_51-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431890\" data-ts=\"1549921320\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431890-bristow-columbia-helicopters-terminate-takeover-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow, Columbia Helicopters terminate takeover deal</a></h4><ul><li>Bristow (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"green\">+7.8%</font> after-hours after <a href=\"https://seekingalpha.com/pr/17408480-bristow-columbia-helicopters-terminate-proposed-transaction\" target=\"_blank\">agreeing to terminate</a> its planned agreement to acquire Columbia Helicopters and to pay a $20M break-up fee.</li><li>BRS says \"the decision to enter into a mutual termination of the purchase agreement was based on a number of developments following the entry into the agreement,\" but the companies are actively considering other opportunities to work together.</li><li>Activist investor Global Value Investment had <a href=\"https://seekingalpha.com/news/3421809-bristows-deal-columbia-helicopters-opposed-activist-investor\" target=\"_blank\">opposed the proposed financing</a> of the deal, saying 33M-33.5M BRS shares would be issued in order to consummate the acquisition, representing a 93% dilution.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431890\" data-linked=\"Bristow, Columbia Helicopters terminate takeover deal\" data-tweet=\"$BRS - Bristow, Columbia Helicopters terminate takeover deal https://seekingalpha.com/news/3431890-bristow-columbia-helicopters-terminate-takeover-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3431890-bristow-columbia-helicopters-terminate-takeover-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431882\" data-ts=\"1549920935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XERS\" target=\"_blank\">XERS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431882-xeris-pharma-down-5-after-hours-on-planned-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xeris Pharma down 5% after hours on planned equity offering</a></h4><ul><li>Xeris Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XERS' title='Xeris Pharmaceuticals'>XERS</a>) slips <font color=\"red\">5%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17408391-xeris-pharmaceuticals-announces-proposed-public-offering-shares-common-stock\" target=\"_blank\">planned public offering</a> of 5M common shares. Price and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431882\" data-linked=\"Xeris Pharma down 5% after hours on planned equity offering\" data-tweet=\"$XERS - Xeris Pharma down 5% after hours on planned equity offering https://seekingalpha.com/news/3431882-xeris-pharma-down-5-after-hours-on-planned-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3431882-xeris-pharma-down-5-after-hours-on-planned-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431875\" data-ts=\"1549920768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNS\" target=\"_blank\">VRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431875-varonisminus-18-on-downside-q1-fy19-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Varonis -18% on downside Q1, FY19 outlook</a></h4><ul><li>Varonis Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a>)Â <font color=\"red\">plunges 18.2%</font>Â after Q4 beats that came with downside Q1 and FY19 guidance.</li><li>Q1 forecast has revenue of $58.5M to $60M (consensus: $62.36M) and EPS of -$0.38 to -$0.36 (consensus: -$0.23).</li><li>FY19 guidance has revenue from $297M to $305M (consensus: $318.12M) and EPS from $0.04 to $0.16 (consensus: $0.32).</li><li>The company attributes the downsides to the impact from the transition to a subscription model.</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://www.varonis.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17408379-varonis-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431822-varonis-beats-0_20-beats-revenue\" target=\"_blank\">Varonis beats by $0.20, beats on revenue</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431875\" data-linked=\"Varonis -18% on downside Q1, FY19 outlook\" data-tweet=\"$VRNS - Varonis -18% on downside Q1, FY19 outlook https://seekingalpha.com/news/3431875-varonisminus-18-on-downside-q1-fy19-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3431875-varonisminus-18-on-downside-q1-fy19-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431869\" data-ts=\"1549920642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOH\" target=\"_blank\">MOH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431869-molina-q4-top-line-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molina Q4 top line  down 6%</a></h4><ul><li>Molina Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a>) <a href=\"https://seekingalpha.com/pr/17408422-molina-healthcare-announces-fourth-quarter-year-end-2018-results-provides-fiscal-year-2019\" target=\"_blank\">Q4 result</a>s ($M): Total revenue:Â 4,664 (-5.8%); Premiums:Â 4,438 (-5.4%).</li><li>Net income:Â 201 (+176.7%); non-GAAP net income:Â 206 (+79.8%); EPS: 3.01 (+165.6%); non-GAAPÂ EPS: 3.07 (+67.9%); cash flow ops: (123) (+19.6%).</li><li>Medical cost ratio: 85.1%.</li><li><strong>2019 guidance</strong>: Total revenue:Â ~$16.3B; premium revenue: ~$15.8B; EPS:Â $9.25 - 9.75; medical care ratio: 86.7 - 87.0%;</li><li>Shares are up a fraction after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431845-molina-healthcare-beats-1_44-beats-revenue\" target=\"_blank\">Molina Healthcare beats by $1.44, beats on revenue</a> (Feb. 11 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431869\" data-linked=\"Molina Q4 top line  down 6%\" data-tweet=\"$MOH - Molina Q4 top line down 6% https://seekingalpha.com/news/3431869-molina-q4-top-line-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3431869-molina-q4-top-line-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431866\" data-ts=\"1549920591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNG\" target=\"_blank\">RNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431866-ringcentralplus-4_9-after-strong-q4-revenues-upbeat-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RingCentral +4.9% after strong Q4 revenues, upbeat guidance</a></h4><ul>   <li>RingCentral (NYSE:<a href='https://seekingalpha.com/symbol/RNG' title='RingCentral, Inc.'>RNG</a>) is <font color=\"green\">up 4.9%</font> after hours following a Q4 beat where revenues grew by a third and the company saw healthy growth in mid-market and enterprise business.</li>    <li>The company swung to a GAAP net loss from break-even a year ago, mainly due to stock-based compensation and acquisition-related costs, and operating margin dropped to -1.8% from -0.2% for the same reasons. Non-GAAP EPS rose to $0.23 from $0.14.</li>    <li>But annualized exit monthly recurring subscriptions rose 33% to $726M; RingCentral Office ARR rose 38% to $644M; and mid-market and enterprise ARR jumped 73% to $309M. Enterprise ARR was up 99% to $171M.</li>     <li>For Q1, it's guiding to revenues of $191.5M-$194.5M (27-29% annual growth, and above consensus for $189.2M), and EPS of $0.14-$0.16 (vs. $0.14 consensus).</li>   <li>For the full year, it's guiding to revenues of $847M-$859M (26-28% annual growth, and above consensus for $823M), and EPS of $0.69-$0.73 (vs. $0.68 consensus).</li>    <li><a href=\"http://ir.ringcentral.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431815-ringcentral-beats-0_05-beats-revenue\" target=\"_blank\">RingCentral beats by $0.05, beats on revenue</a> (Feb. 11 2019)</li>   <li><a href=\"https://seekingalpha.com/pr/17408357-ringcentral-announces-fourth-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3431866\" data-linked=\"RingCentral +4.9% after strong Q4 revenues, upbeat guidance\" data-tweet=\"$RNG - RingCentral +4.9% after strong Q4 revenues, upbeat guidance https://seekingalpha.com/news/3431866-ringcentralplus-4_9-after-strong-q4-revenues-upbeat-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3431866-ringcentralplus-4_9-after-strong-q4-revenues-upbeat-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431847\" data-ts=\"1549919955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITT\" target=\"_blank\">MITT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431847-ag-mortgage-hits-capital-raise-button\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AG Mortgage hits the capital raise button</a></h4><ul><li>AG Mortgage (NYSE:<a href='https://seekingalpha.com/symbol/MITT' title='AG Mortgage Investment Trust, Inc.'>MITT</a>) is <a href=\"https://seekingalpha.com/pr/17408397-ag-mortgage-investment-trust-inc-announces-public-offering-common-stock\" target=\"_blank\">offering 3M shares</a> with 450K underwriter greenshoe.</li><li>The company <a href=\"https://seekingalpha.com/news/3431632-ag-mortgage-estimates-bv-fell-10-percent-q4-2-percent-january\" target=\"_blank\">this morning pre-announced</a> a rough Q4, with book value per share falling an estimated 10.2% to $17.21. January saw a small recovery, with BVPS rising about 2%.</li><li>Today's close of $17.80 looks a modest premium to end-of-January book value.</li><li>The stockÂ <font color=\"red\">fell 2%</font>Â in today's session, and isÂ <font color=\"red\">off another 1.5%Â </font>after hours to $17.53.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431847\" data-linked=\"AG Mortgage hits the capital raise button\" data-tweet=\"$MITT - AG Mortgage hits the capital raise button https://seekingalpha.com/news/3431847-ag-mortgage-hits-capital-raise-button?source=tweet\" data-url=\"https://seekingalpha.com/news/3431847-ag-mortgage-hits-capital-raise-button\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431841\" data-ts=\"1549919852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGI\" target=\"_blank\">MGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431841-moneygramminus-8-after-light-q4-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoneyGram -8% after light Q4 profit</a></h4><ul><li>MoneyGram International (NYSE:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) falls sharply after <a href=\"https://seekingalpha.com/pr/17408353-moneygram-international-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4</a> results disappoint. The company scratched out a $0.01 profit for the quarter after analysts expected EPS of $0.12.</li><li>Adjusted EBITDA fell 11% Y/Y toÂ $60M during the quarter. Adjusted free cash flow was $21.1M vs. $25.7M a year ago.</li><li>Looking ahead, MoneyGram expects FY19 revenue growth of -4% to -2%, which has a midpoint below the consensus estimate.</li><li>MGIÂ <font color=\"red\">-8.5%</font>Â AH.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431816-moneygram-misses-0_11-misses-revenue\" target=\"_blank\">MoneyGram misses by $0.11, misses on revenue</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431841\" data-linked=\"MoneyGram -8% after light Q4 profit\" data-tweet=\"$MGI - MoneyGram -8% after light Q4 profit https://seekingalpha.com/news/3431841-moneygramminus-8-after-light-q4-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3431841-moneygramminus-8-after-light-q4-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431835\" data-ts=\"1549919776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMKR\" target=\"_blank\">AMKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431835-amkorminus-6_7-on-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amkor -6.7% on downside guidance</a></h4><ul><li>Amkor Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/AMKR' title='Amkor Technology, Inc.'>AMKR</a>)Â <font color=\"red\">drops 6.7%</font>Â after Q4 beats with downside Q1 guidance that has revenue from $840M to $920M (consensus: $1.01B) and EPS from -$0.27 to -$0.07 (consensus: $0.03). Amkor attributes the outlook to inventory corrections underway in the smartphone market.</li><li>For FY19, AMKR expects capex of around $475M.</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"https://amkor.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17408396-amkor-technology-reports-financial-results-fourth-quarter-full-year-2018\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431825-amkor-technology-beats-0_11-beats-revenue\" target=\"_blank\">Amkor Technology beats by $0.11, beats on revenue</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431835\" data-linked=\"Amkor -6.7% on downside guidance\" data-tweet=\"$AMKR - Amkor -6.7% on downside guidance https://seekingalpha.com/news/3431835-amkorminus-6_7-on-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3431835-amkorminus-6_7-on-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431830\" data-ts=\"1549919561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLGT\" target=\"_blank\">RLGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431830-radiant-logistics-beats-0_06\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radiant Logistics beats by $0.06</a></h4><ul><li>Radiant Logistics (NYSEMKT:<a href='https://seekingalpha.com/symbol/RLGT' title='Radiant Logistics, Inc.'>RLGT</a>): Q2 Non-GAAP EPS of $0.16 <span style=\"color:green\">beats by $0.06</span>; GAAP EPS of $0.07 <span style=\"color:red\">misses by $0.03</span>.</li><li>Revenue of $260.94M (+26.2% Y/Y)</li><li>Shares <font color=\"green\">+2.95%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17408346-radiant-logistics-announces-results-second-fiscal-quarter-ended-december-31-2018\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3431830\" data-linked=\"Radiant Logistics beats by $0.06\" data-tweet=\"$RLGT - Radiant Logistics beats by $0.06 https://seekingalpha.com/news/3431830-radiant-logistics-beats-0_06?source=tweet\" data-url=\"https://seekingalpha.com/news/3431830-radiant-logistics-beats-0_06\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431827\" data-ts=\"1549919438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHGG\" target=\"_blank\">CHGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431827-chegg-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chegg beats by $0.04, beats on revenue</a></h4><ul><li>Chegg (NYSE:<a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a>): Q4 Non-GAAP EPS of $0.25 <span style=\"color:green\">beats by $0.04</span>; GAAP EPS of $0.04 in-line.</li><li>Revenue of $95.67M (+30.1% Y/Y) <font color=\"green\">beats by $4.07M</font>.</li><li>Shares <font color=\"green\">+7.79%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17408370-chegg-reports-q4-full-year-2018-financial-results-raises-2019-guidance\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3431827\" data-linked=\"Chegg beats by $0.04, beats on revenue\" data-tweet=\"$CHGG - Chegg beats by $0.04, beats on revenue https://seekingalpha.com/news/3431827-chegg-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3431827-chegg-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431826\" data-ts=\"1549919427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHGG\" target=\"_blank\">CHGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431826-chegg-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chegg beats by $0.04, beats on revenue</a></h4><ul><li>Chegg (NYSE:<a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a>): Q4 Non-GAAP EPS of $0.25 <span style=\"color:green\">beats by $0.04</span>; GAAP EPS of $0.04 in-line.</li><li>Revenue of $95.67M (+30.1% Y/Y) <font color=\"green\">beats by $4.07M</font>.</li><li>Shares <font color=\"green\">+7.79%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17408370-chegg-reports-q4-full-year-2018-financial-results-raises-2019-guidance\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3431826\" data-linked=\"Chegg beats by $0.04, beats on revenue\" data-tweet=\"$CHGG - Chegg beats by $0.04, beats on revenue https://seekingalpha.com/news/3431826-chegg-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3431826-chegg-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431817\" data-ts=\"1549919129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431817-t-rowe-price-big-seller-of-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T. Rowe Price a big seller of Tesla</a></h4><ul> <li>T Rowe Price Group reduced its position in Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) to 8.98M shares at the end of Q4, according to a new filing.</li> <li>The fund manager held 17.4M shares at the end of Q3.</li> <li>The selling by T. Rowe during the quarter reduced its ownership stake in Tesla to 5.2%.</li> <li>Shares of Tesla ended the day <font color=\"green\">up 2.30%</font> to $312.84.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3431817\" data-linked=\"T. Rowe Price a big seller of Tesla\" data-tweet=\"$TSLA - T. Rowe Price a big seller of Tesla https://seekingalpha.com/news/3431817-t-rowe-price-big-seller-of-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3431817-t-rowe-price-big-seller-of-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>175&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431809\" data-ts=\"1549918447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCI\" target=\"_blank\">GCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431809-mng-rebuts-characterization-of-meeting-gannett\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MNG rebuts characterization of meeting with Gannett</a></h4><ul>   <li>The latest in what's becoming an increasingly hostile back-and-forth over a proposal to acquire Gannett (<a href=\"http://seekingalpha.com/symbol/GCI\" target=\"_blank\">GCI</a> <font color=\"red\">-2.1%</font>) comes from suitor MNG, who responds to <a href=\"https://seekingalpha.com/news/3431701-gannett-presses-defense-mng-bid-new-response\" target=\"_blank\">today's Gannett note</a> by reiterating the company <a href=\"https://seekingalpha.com/pr/17408264-mng-enterprises-responds-gannett-s-misleading-comments-mng-proposal\" target=\"_blank\">can't achieve its bid value on its own</a>.</li>    <li>\u201cGannett grossly mischaracterized the meeting we had last week, as well as MNG\u2019s ability to close this transaction,\" MNG says in its reply. \"MNG expects to have fully committed financing in place within weeks, and the pro forma leverage profile of the combined companies would be very conservative relative to industry comparables. Further, MNG can complete its diligence within four weeks with the cooperation of Gannett.\"</li>    <li>Under the watch of Chairman Jeff Louis, Gannett has seen adjusted EBITDA decline 31% and free cash flow by 50%, MNG says.</li><li>It's offering $12/share in cash, while Gannett is at $10.92.</li>    <li>MNG has a 7.5% stake in Gannett.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431809\" data-linked=\"MNG rebuts characterization of meeting with Gannett\" data-tweet=\"$GCI - MNG rebuts characterization of meeting with Gannett https://seekingalpha.com/news/3431809-mng-rebuts-characterization-of-meeting-gannett?source=tweet\" data-url=\"https://seekingalpha.com/news/3431809-mng-rebuts-characterization-of-meeting-gannett\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431806\" data-ts=\"1549917598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431806-net-price-of-catalyst-pharmas-firdapse-to-be-300k-per-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Net price of Catalyst Pharma&#39;s Firdapse to be $300K+ per year</a></h4><ul><li>Catalyst Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a> <font color=\"green\">+2.4%</font>) <a href=\"https://www.reuters.com/article/us-catalyst-pharms-drugpricing/catalyst-pharma-sees-net-price-of-drug-once-free-topping-300000-idUSKCN1Q0286\" target=\"_blank\">says </a>that the net price per year for LEMS med Firdapse (amifampridine) will be $300K - 318,750 per year, representing about a 15 - 20% discount off the $375K list price. The net price includes rebates to insurers and other discounts.</li><li>The discount, whatever it will be, means little to LEMS patients since they were previously getting it for free from New Jersey-based Jacobus Pharmaceuticals under the FDA's compassionate use program.</li><li>On cue, Senator Bernie Sanders (I-VT) has sent a letter to the company asking it to justify the price.</li><li>Catalyst acquired the rights to the drug from BioMarin Pharmaceutical in 2012.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431806\" data-linked=\"Net price of Catalyst Pharma&#39;s Firdapse to be $300K+ per year\" data-tweet=\"$CPRX - Net price of Catalyst Pharma&#39;s Firdapse to be $300K+ per year https://seekingalpha.com/news/3431806-net-price-of-catalyst-pharmas-firdapse-to-be-300k-per-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3431806-net-price-of-catalyst-pharmas-firdapse-to-be-300k-per-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431797\" data-ts=\"1549916474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALE\" target=\"_blank\">ALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431797-alleteminus-3-mizuho-downgrades-following-water-services-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allete -3% as Mizuho downgrades following water services sale</a></h4><ul><li>Allete (<a href='https://seekingalpha.com/symbol/ALE' title='ALLETE, Inc.'>ALE</a> <font color=\"red\">-3.1%</font>) turns sharply lower from its highest levels in two months after Mizuho <a href=\"https://thefly.com/thestreet/realmoney/index.php/ALEid2862108/ALE-Allete-downgraded-to-Underperform-from-Neutral-at-Mizuho\" target=\"_blank\">downgrades</a> shares to Underperform and trims its price target to $72 from $74, saying the company will face additional execution pressure on its remaining business segments following its <a href=\"https://seekingalpha.com/news/3431214-allete-sell-u-s-water-services-kurita-water\" target=\"_blank\">decision to sell</a> its U.S. Water Services business.</li><li>Mizuho analyst Paul Fremont believes ALE will need to \"fill the earnings gap\" with investments at the Ace segment and/or the regulated subsidiary in order to maintain its 5%-7% annual growth guidance.</li><li>The firm also thinks ALE will miss on the midpoint of its fiscal 2018 guidance due to weak equipment sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431797\" data-linked=\"Allete -3% as Mizuho downgrades following water services sale\" data-tweet=\"$ALE - Allete -3% as Mizuho downgrades following water services sale https://seekingalpha.com/news/3431797-alleteminus-3-mizuho-downgrades-following-water-services-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3431797-alleteminus-3-mizuho-downgrades-following-water-services-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431794\" data-ts=\"1549915655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431794-theater-stocks-tumble-after-lego-movie-fails-to-deliver\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Theater stocks tumble after Lego movie fails to deliver</a></h4><ul> <li>A disastrous opening for <em>The Lego Movie 2</em> is hitting the exhibitor sector hard today.</li> <li>The Warner Bros. film only brought in $34.4M in the U.S. during the weekend to trail expectations for around $50M. There was some hope going into the weekend that the Lego installment would help turn around the slow start to the post-holiday movie season.</li> <li>After taking in the response of moviegoers, B. Riley lowers its estimate for Q1 U.S. box office sales growth to -12.2% from a prior estimate of -10.5%.</li> <li>Cinemark (<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a> <font color=\"red\">-5%</font>), AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color=\"red\">-4.7%</font>), Marcus Corporation (<a href='https://seekingalpha.com/symbol/MCS' title='Marcus Corporation'>MCS</a> <font color=\"red\">-2.1%</font>), IMAX (<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a> <font color=\"red\">-2.6%</font>) and National CineMedia (<a href='https://seekingalpha.com/symbol/NCMI' title='National CineMedia, Inc.'>NCMI</a> <font color=\"red\">-5%</font>) are all notably lower in U.S. trading - while Cineplex (<a href='https://seekingalpha.com/symbol/CPXGF' title='Cineplex, Inc.'>OTCPK:CPXGF</a>) is <font color=\"red\">down 2.7%</font> in Toronto trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431794\" data-linked=\"Theater stocks tumble after Lego movie fails to deliver\" data-tweet=\"$CNK $AMC $MCS - Theater stocks tumble after Lego movie fails to deliver https://seekingalpha.com/news/3431794-theater-stocks-tumble-after-lego-movie-fails-to-deliver?source=tweet\" data-url=\"https://seekingalpha.com/news/3431794-theater-stocks-tumble-after-lego-movie-fails-to-deliver\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431793\" data-ts=\"1549915340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431793-zayo-heads-lower-on-report-of-lower-private-equity-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zayo heads lower on report of lower private-equity bid</a></h4><ul>   <li>Zayo Group (NYSE:<a href='https://seekingalpha.com/symbol/ZAYO' title='Zayo Group'>ZAYO</a>) has moved into negative ground, now <font color=\"red\">down 4.3%</font>, after a CTFN report says a revised offer for the company has come in lower than the last one.</li>    <li>The latest bid is now for about $30/share, according to the report.</li>    <li>That's below what chatter had as a bid in the <a href=\"https://seekingalpha.com/news/3426217-zayo-jumps-8_6-percent-chatter-alphabet-centurylink-interest\" target=\"_blank\">low- to mid-$30s</a> late last month.</li>    <li>Shares are currently at $25.12, down $1.19.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431793\" data-linked=\"Zayo heads lower on report of lower private-equity bid\" data-tweet=\"$ZAYO - Zayo heads lower on report of lower private-equity bid https://seekingalpha.com/news/3431793-zayo-heads-lower-on-report-of-lower-private-equity-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3431793-zayo-heads-lower-on-report-of-lower-private-equity-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431792\" data-ts=\"1549915070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431792-microcaps-tops-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps tops tech movers</a></h4><ul><li><strong>Gainers:Â </strong>SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"green\">+43%</font>. SilverSun Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SSNT' title='SilverSun Technologies, Inc.'>SSNT</a>) <font color=\"green\">+31%</font>. CLPS Incorporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a>) <font color=\"green\">+27%</font>. Creative Realities (NASDAQ:<a href='https://seekingalpha.com/symbol/CREX' title='Creative Realities, Inc.'>CREX</a>) <font color=\"green\">+24%</font>. CounterPath (NASDAQ:<a href='https://seekingalpha.com/symbol/CPAH' title='CounterPath Corporation'>CPAH</a>) <font color=\"green\">+21%</font>.</li> <li><strong>Losers:Â </strong>Kopin Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/KOPN' title='Kopin Corporation'>KOPN</a>) <font color=\"red\">-18%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a>) <font color=\"red\">-11%</font>. The Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) <font color=\"red\">-10%</font>. QuinStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/QNST' title='QuinStreet, Inc.'>QNST</a>) <font color=\"red\">-10%</font>. GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431792\" data-linked=\"Microcaps tops tech movers\" data-tweet=\"$SPI $SSNT $CLPS - Microcaps tops tech movers https://seekingalpha.com/news/3431792-microcaps-tops-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431792-microcaps-tops-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431791\" data-ts=\"1549914893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AR\" target=\"_blank\">AR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431791-antero-resources-doj-reach-settlement-for-clean-water-act-violations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Resources, DoJ reach settlement for Clean Water Act violations</a></h4><ul><li>The Department of Justice says it <a href=\"https://www.justice.gov/opa/pr/u-s-and-west-virginia-reach-settlement-antero-resources-corporation-clean-water-act\" target=\"_blank\">reached a settlement</a> with Antero Resources (<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color='green'>+2.2%</font>) over claims the company violated the Clean Water Act at 32 different sites in West Virginia, <a href=\"https://www.reuters.com/article/us-usa-antero/u-s-settles-with-antero-over-water-pollution-from-fracking-idUSKCN1Q021K\" target=\"_blank\">mostly tied to fracking</a>.</li><li>AR agrees to pay a $3.15M penalty and provide mitigation and restoration of affected sites, estimated to cost $8M, related to violations involving unauthorized disposal of materials into local waterways through fracking, the DoJ says.</li><li>AR identified roughly half of the sites through its own self-audit, the DoJ says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431791\" data-linked=\"Antero Resources, DoJ reach settlement for Clean Water Act violations\" data-tweet=\"$AR - Antero Resources, DoJ reach settlement for Clean Water Act violations https://seekingalpha.com/news/3431791-antero-resources-doj-reach-settlement-for-clean-water-act-violations?source=tweet\" data-url=\"https://seekingalpha.com/news/3431791-antero-resources-doj-reach-settlement-for-clean-water-act-violations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431777\" data-ts=\"1549911452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431777-fts-international-and-forum-energy-technologies-among-energy-materials-gainers-mountain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTS International and Forum Energy Technologies among Energy/Materials gainers; Mountain Province Diamonds and Amyris among losers</a></h4><ul><li><b>Gainers:Â </b>FTS International (NYSE:<a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a>) <font color=\"green\">+13%</font>. Forum Energy Technologies (NYSE:<a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies'>FET</a>) <font color=\"green\">+11%</font>. VAALCO Energy (NYSE:<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>) <font color=\"green\">+9%</font>. Range Resources (NYSE:<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a>) <font color=\"green\">+8%</font>. Ferrellgas Partners (NYSE:<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:Â </b>Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-12%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-8%</font>. Diamond Offshore Drilling (NYSE:<a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431777\" data-linked=\"FTS International and Forum Energy Technologies among Energy/Materials gainers; Mountain Province Diamonds and Amyris among losers\" data-tweet=\"$FTSI $FET $EGY - FTS International and Forum Energy Technologies among Energy/Materials gainers; Mountain Province Diamonds and Amyris among losers https://seekingalpha.com/news/3431777-fts-international-and-forum-energy-technologies-among-energy-materials-gainers-mountain?source=tweet\" data-url=\"https://seekingalpha.com/news/3431777-fts-international-and-forum-energy-technologies-among-energy-materials-gainers-mountain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431775\" data-ts=\"1549911342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431775-wisdomtree-explored-sale-late-last-year-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WisdomTree explored a sale late last year: Bloomberg</a></h4><ul><li>WisdomTree (<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a> <font color='green'>+5.9%</font>) <a href=\"https://www.bloomberg.com/news/articles/2019-02-11/wisdomtree-is-said-to-have-explored-sale-to-jpmorgan-chase?utm_campaign=socialflow-organic&amp;utm_content=business&amp;utm_source=twitter&amp;cmpid=socialflow-twitter-business&amp;utm_medium=social\" target=\"_blank\">explored a sale</a> late last year and held talks with JPMorgan Chase (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='red'>-0.1%</font>), but negotiations fell apart when they couldn't agree on a price as WETF's shares sank during the December market turmoil, Bloomberg reports, citing people familiar with the matter.</li><li>The asset manager isn't currently pursuing a sale, they said.</li><li>WETF shares rose as much as 7.2% today; since the end of November, WisdomTree fell about 16% to close at $5.97 on Friday, Feb. 8, 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428639-wisdomtree-minus-6-percent-aum-slips-advisory-fee-rate-shrinks\" target=\"_blank\">WisdomTree -6% as AUM slips, advisory fee rate shrinks</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431775\" data-linked=\"WisdomTree explored a sale late last year: Bloomberg\" data-tweet=\"$WETF $JPM - WisdomTree explored a sale late last year: Bloomberg https://seekingalpha.com/news/3431775-wisdomtree-explored-sale-late-last-year-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3431775-wisdomtree-explored-sale-late-last-year-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431774\" data-ts=\"1549911201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431774-citi-replaces-top-pick-nvidia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi replaces Top Pick Nvidia</a></h4><ul><li>Citi lowers its Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) price target from $244 to $200 and replaces the company with Marvell (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) as its Top Pick.</li><li>Late last month, Nvidia <a href=\"https://seekingalpha.com/news/3426409-nvidia-minus-15-percent-q4-guidance-cut\" target=\"_blank\">cut</a> its Q4 revenue guidance on weaker than expected sales of its gaming and datacenter platforms.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431584-bernstein-downgardes-nvidia-increasing-headline-risk\" target=\"_blank\">Bernstein downgardes Nvidia on increasing headline risk</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431774\" data-linked=\"Citi replaces Top Pick Nvidia\" data-tweet=\"$NVDA $MRVL - Citi replaces Top Pick Nvidia https://seekingalpha.com/news/3431774-citi-replaces-top-pick-nvidia?source=tweet\" data-url=\"https://seekingalpha.com/news/3431774-citi-replaces-top-pick-nvidia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431769\" data-ts=\"1549910388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTHF\" target=\"_blank\">VRTHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431769-veritas-pharma-advancing-presence-in-puerto-rico\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veritas Pharma advancing presence in Puerto Rico</a></h4><ul><li>Veritas Pharma (<a href='https://seekingalpha.com/symbol/VRTHF' title='Veritas Pharma Inc'>OTCPK:VRTHF</a>) <a href=\"https://seekingalpha.com/pr/17408155-veritas-leads-puerto-rico-partnership-approval-new-investigation-license\" target=\"_blank\">announces </a>that the Puerto Rico Medicinal Cannabis Regulatory Board has signed off on an Investigation License allowing the clinical evaluation of lead cannabis product CTL-X for relieving acute pain. The company is developing the candidate in collaboration with the Institute for Medicinal Cannabis and the Fundacion de Investigacion, Puerto Rico's leading medical cannabis researchers.</li><li>A three-month clinical trial should commence this week.</li><li>Shares are up <font color=\"green\">2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431769\" data-linked=\"Veritas Pharma advancing presence in Puerto Rico\" data-tweet=\"$VRTHF - Veritas Pharma advancing presence in Puerto Rico https://seekingalpha.com/news/3431769-veritas-pharma-advancing-presence-in-puerto-rico?source=tweet\" data-url=\"https://seekingalpha.com/news/3431769-veritas-pharma-advancing-presence-in-puerto-rico\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431765\" data-ts=\"1549910099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENB\" target=\"_blank\">TENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431765-tenableplus-2-on-buy-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenable +2% on Buy initiation</a></h4><ul><li>Summit Insights starts Tenable (NASDAQ:<a href='https://seekingalpha.com/symbol/TENB' title='Tenable Holdings, Inc.'>TENB</a>) with a Buy rating and $35 target, a 27% upside.</li><li>Earlier this month, Tenable <a href=\"https://seekingalpha.com/news/3429826-tenable-holdings-reports-q4-results\" target=\"_blank\">reported Q4 result</a>s that featured 39% Y/Y revenue growth. Q1 guidance includes upside revenue from $77.5M to $78.5M and in-line EPS from -$0.19 to -$0.18.</li><li>Upside FY19 guidance has revenue of $338M to $343M and EPS from -$0.62 to -$0.57.</li><li>Tenable shares areÂ <font color=\"green\">up 2.4%</font>Â to $27.64.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431765\" data-linked=\"Tenable +2% on Buy initiation\" data-tweet=\"$TENB - Tenable +2% on Buy initiation https://seekingalpha.com/news/3431765-tenableplus-2-on-buy-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3431765-tenableplus-2-on-buy-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431764\" data-ts=\"1549909800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FND\" target=\"_blank\">FND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431764-gordon-haskett-cautious-on-floor-decor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gordon Haskett cautious on Floor &amp; Decor</a></h4><ul> <li>Floor &amp; Decor (<a href='https://seekingalpha.com/symbol/FND' title='Floor & Decor Holdings, Inc.'>FND</a> <font color='red'>-0.6%</font>) slips after Gordon Haskett downgrades the retailer to a Hold rating from Accumulate.</li> <li>The firm cools off on Floor &amp; Decor after accounting for the 24% YTD share price gain in the face of an outlook for a weaker overall macro housing landscape.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3431764\" data-linked=\"Gordon Haskett cautious on Floor &amp; Decor\" data-tweet=\"$FND - Gordon Haskett cautious on Floor &amp; Decor https://seekingalpha.com/news/3431764-gordon-haskett-cautious-on-floor-decor?source=tweet\" data-url=\"https://seekingalpha.com/news/3431764-gordon-haskett-cautious-on-floor-decor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431763\" data-ts=\"1549909088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431763-cbs-lower-after-cut-to-neutral-atlantic-equities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS lower after cut to Neutral at Atlantic Equities</a></h4><ul>   <li>CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color=\"red\">-2.5%</font>) has seen a downgrade to Neutral at Atlantic Equities.</li>    <li>The firm trimmed its recommendation from Overweight, departing from a majority-bulllish Street.</li>    <li>It's cut its price target to $56 from $67, implying 16% upside from current pricing.</li>    <li>A decent start to 2019 took the edge off what's now a three-month price decline of 14.2%; shares are <font color=\"green\">up 13.4%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431763\" data-linked=\"CBS lower after cut to Neutral at Atlantic Equities\" data-tweet=\"$CBS $VIAC - CBS lower after cut to Neutral at Atlantic Equities https://seekingalpha.com/news/3431763-cbs-lower-after-cut-to-neutral-atlantic-equities?source=tweet\" data-url=\"https://seekingalpha.com/news/3431763-cbs-lower-after-cut-to-neutral-atlantic-equities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431752\" data-ts=\"1549908103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENOB\" target=\"_blank\">ENOB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431752-enochian-bio-up-19-on-investor-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enochian Bio up 19% on investor update</a></h4><ul><li>Thinly traded micro cap Enochian Biosciences (<a href='https://seekingalpha.com/symbol/ENOB' title='Enochian Biosciences Inc.'>OTCQB:ENOB</a> <font color=\"green\">+19.2%</font>)Â is up on more than double normal volume, albeit on turnover of only 90K shares, ahead of today's <a href=\"https://www.sec.gov/Archives/edgar/data/1527728/000173112219000040/e1240_99-1.htm\" target=\"_blank\">investor event</a>.</li><li>The company's pipeline includes preventative and therapeutic HIV vaccines and dendritic cell vaccines for cancer.</li><li>On the working capital front, at the end of September, it had $13.4M in cash while operations <a href=\"https://www.sec.gov/Archives/edgar/data/1527728/000173112218000163/e1193_form10q.htm\" target=\"_blank\">consumed </a>$1.8M during the quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431752\" data-linked=\"Enochian Bio up 19% on investor update\" data-tweet=\"$ENOB - Enochian Bio up 19% on investor update https://seekingalpha.com/news/3431752-enochian-bio-up-19-on-investor-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3431752-enochian-bio-up-19-on-investor-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431751\" data-ts=\"1549908003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431751-china-bat-group-among-financial-gainers-and-cna-financial-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Bat Group among financial gainers and CNA Financial among losers</a></h4><ul><li><b>Gainers:Â </b>China Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Commercial Credit, Inc.'>GLG</a>) <font color=\"green\">+6%</font>. Great Elm Capital Group (NYSE:<a href='https://seekingalpha.com/symbol/GEC' title='Great Elm Capital Group, Inc.'>GEC</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:Â </b>Mercury General (NYSE:<a href='https://seekingalpha.com/symbol/MCY' title='Mercury General Corporation'>MCY</a>) <font color=\"red\">-7%</font>. CNA Financial (NYSE:<a href='https://seekingalpha.com/symbol/CNA' title='CNA Financial Corporation'>CNA</a>) <font color=\"red\">-6%</font>. Loews (NYSE:<a href='https://seekingalpha.com/symbol/L' title='Loews Corporation'>L</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431751\" data-linked=\"China Bat Group among financial gainers and CNA Financial among losers\" data-tweet=\"$GLG $GEC $MCY - China Bat Group among financial gainers and CNA Financial among losers https://seekingalpha.com/news/3431751-china-bat-group-among-financial-gainers-and-cna-financial-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431751-china-bat-group-among-financial-gainers-and-cna-financial-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431747\" data-ts=\"1549907064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431747-microcaps-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate midday movers</a></h4><ul><li><strong>Gainers:Â </strong>SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"green\">+45%</font>. SilverSun Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SSNT' title='SilverSun Technologies, Inc.'>SSNT</a>) <font color=\"green\">+30%</font>. Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a>) <font color=\"green\">+26%</font>. Enochian Biosciences (<a href='https://seekingalpha.com/symbol/ENOB' title='Enochian Biosciences Inc.'>OTCQB:ENOB</a>) <font color=\"green\">+20%</font>. Nemaura Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a>) <font color=\"green\">+19%</font>. Select Interior Concepts (NASDAQ:<a href='https://seekingalpha.com/symbol/SIC' title='Select Interior Concepts Inc'>SIC</a>) <font color=\"green\">+18%</font>. Replimune Group (NASDAQ:<a href='https://seekingalpha.com/symbol/REPL' title='Replimune Group'>REPL</a>) <font color=\"green\">+15%</font>. Insperity (NYSE:<a href='https://seekingalpha.com/symbol/NSP' title='Insperity, Inc.'>NSP</a>) <font color=\"green\">+15%</font>. NuVasive (NASDAQ:<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a>) <font color=\"green\">+15%</font>. SCYNEXIS (NASDAQ:<a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers:Â </strong>Fuling Global (NASDAQ:<a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global'>FORK</a>) <font color=\"red\">-19%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a>) <font color=\"red\">-19%</font>. Kopin (NASDAQ:<a href='https://seekingalpha.com/symbol/KOPN' title='Kopin Corporation'>KOPN</a>) <font color=\"red\">-16%</font>. Mustang Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MBIO' title='Mustang Bio, Inc.'>MBIO</a>) <font color=\"red\">-15%</font>. Celldex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a>) <font color=\"red\">-14%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-14%</font>. TMSR Holding Company (NASDAQ:<a href='https://seekingalpha.com/symbol/TMSR' title='TMSR Holding Co., Ltd.'>TMSR</a>) <font color=\"red\">-11%</font>. NantKwest (NASDAQ:<a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a>) <font color=\"red\">-11%</font>. The Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) <font color=\"red\">-11%</font>. Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431747\" data-linked=\"Microcaps dominate midday movers\" data-tweet=\"$SPI $SSNT $PTI - Microcaps dominate midday movers https://seekingalpha.com/news/3431747-microcaps-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431747-microcaps-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431743\" data-ts=\"1549906433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431743-celgene-prevails-in-revlimid-patent-challenge-from-dr-reddys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene prevails in Revlimid patent challenge from Dr. Reddy&#39;s</a></h4><ul><li>The USPTO has declined to sign off on an inter partes review of Celgene's (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"green\">+2.1%</font>)Â U.S. Patent No. 8,404,717 covering top seller Revlimid, requested by would-be generic competitor Dr. Reddy's Laboratories (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color=\"red\">-5.1%</font>).</li><li>The USPTO will decide on two additional patents, No. 9,056,120 and No. 7,189,740, any day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431743\" data-linked=\"Celgene prevails in Revlimid patent challenge from Dr. Reddy&#39;s\" data-tweet=\"$CELG $CELG $RDY - Celgene prevails in Revlimid patent challenge from Dr. Reddy&#39;s https://seekingalpha.com/news/3431743-celgene-prevails-in-revlimid-patent-challenge-from-dr-reddys?source=tweet\" data-url=\"https://seekingalpha.com/news/3431743-celgene-prevails-in-revlimid-patent-challenge-from-dr-reddys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431737\" data-ts=\"1549905237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMRD\" target=\"_blank\">NMRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431737-nemaura-medical-up-20-ahead-of-u-s-application-for-sugarbeat-cgm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nemaura Medical up 20% ahead of U.S. application for sugarBEAT CGM</a></h4><ul><li>Thinly traded micro cap Nemaura Medical (<a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a> <font color=\"green\">+20.4%</font>) is up up almost a 10x surge in volume. No particular news accounts for the action but the company <a href=\"https://seekingalpha.com/news/3389717-nemaura-closing-u-s-marketing-application-cgm-sugarbeat-shares-49-percent\" target=\"_blank\">expects to file</a> a U.S. marketing application this quarter for continuous glucose monitor &#40;CGM&#41;Â sugarBEAT.</li><li>On Friday, February 8, it filed an <a href=\"https://www.sec.gov/Archives/edgar/data/1602078/000107997319000062/nemaura_8k.htm\" target=\"_blank\">8-K</a> disclosing that CFO Iain Anderson resigned effective immediately. President &amp; CEO Dewan Chowdhury has assumed his duties on an interim basis until a permanent successor is on board.</li><li>In mid-December, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1602078/000107997318000687/nemaura_424b5.htm\" target=\"_blank\">prospectus supplement</a> for an offer of 2.4M common shares and accompanying five-year warrants to purchase up to the same number of shares at $1.04 per share and warrant to placement agent Dawson James Securities who will use its \"best efforts\" to resell the equity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431737\" data-linked=\"Nemaura Medical up 20% ahead of U.S. application for sugarBEAT CGM\" data-tweet=\"$NMRD - Nemaura Medical up 20% ahead of U.S. application for sugarBEAT CGM https://seekingalpha.com/news/3431737-nemaura-medical-up-20-ahead-of-u-s-application-for-sugarbeat-cgm?source=tweet\" data-url=\"https://seekingalpha.com/news/3431737-nemaura-medical-up-20-ahead-of-u-s-application-for-sugarbeat-cgm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431734\" data-ts=\"1549904466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431734-avon-products-and-lovesac-company-consumer-gainers-fuling-global-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avon Products and The Lovesac Company consumer gainers; Fuling Global leads the losers</a></h4><ul><li><b>Gainers:Â </b>The Lovesac Company (NASDAQ:<a href='https://seekingalpha.com/symbol/LOVE' title='The Lovesac Company'>LOVE</a>) <font color=\"green\">+8%</font>. Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:Â </b>Fuling Global (NASDAQ:<a href='https://seekingalpha.com/symbol/FORK' title='Fuling Global'>FORK</a>) <font color=\"red\">-19%</font>. Natuzzi (NYSE:<a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a>)Â <font color=\"red\">-8%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431734\" data-linked=\"Avon Products and The Lovesac Company consumer gainers; Fuling Global leads the losers\" data-tweet=\"$LOVE $AVP $FORK - Avon Products and The Lovesac Company consumer gainers; Fuling Global leads the losers https://seekingalpha.com/news/3431734-avon-products-and-lovesac-company-consumer-gainers-fuling-global-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431734-avon-products-and-lovesac-company-consumer-gainers-fuling-global-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431732\" data-ts=\"1549904227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USAT\" target=\"_blank\">USAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431732-usa-technologiesminus-6_6-on-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USA Technologies -6.6% on downgrade</a></h4><ul><li>Lake Street downgrades USA Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a>) from Buy to Hold and lowers the target from $7.50 to $4.50, an 18% upside to the last close.</li><li>Earlier this month, USAT <a href=\"https://seekingalpha.com/news/3430577-usa-technologies-restate-financial-statement-shares-minus-24-percent\" target=\"_blank\">announced</a> it would restate some financial statements and the resignation of its independent accounting firm.</li><li>USAT shares areÂ <font color=\"red\">down 6.6%</font>Â to $3.55.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431732\" data-linked=\"USA Technologies -6.6% on downgrade\" data-tweet=\"$USAT - USA Technologies -6.6% on downgrade https://seekingalpha.com/news/3431732-usa-technologiesminus-6_6-on-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3431732-usa-technologiesminus-6_6-on-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431731\" data-ts=\"1549904107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTI\" target=\"_blank\">PTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431731-proteostasis-up-24-on-blackrock-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proteostasis up 24% on BlackRock stake</a></h4><ul><li>Proteostasis Therapeutics (<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color=\"green\">+24%</font>) is up on more than double normal volume. After the close on Friday, February 8, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1364742/000021545719006898/us74373B1098_020719.txt\" target=\"_blank\">13G </a>disclosing 5.9% stake (~2.92M shares) by BlackRock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431731\" data-linked=\"Proteostasis up 24% on BlackRock stake\" data-tweet=\"$PTI - Proteostasis up 24% on BlackRock stake https://seekingalpha.com/news/3431731-proteostasis-up-24-on-blackrock-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3431731-proteostasis-up-24-on-blackrock-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431730\" data-ts=\"1549904022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431730-fox-angels-owner-may-throw-hat-regional-sports-net-ring\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox: Angels owner may throw hat into regional sports net ring</a></h4><ul>   <li>Los Angeles Angels owner Arte Moreno has emerged as another possibility in the auction of the Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color=\"red\">-0.2%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color=\"red\">-0.1%</font>) regional sports networks, with an <a href=\"https://www.foxbusiness.com/media/fox-rsn-sale-grows-more-confusing-as-angels-owner-eyes-several-networks\" target=\"_blank\">interest in as many as four</a> of the RSN, Fox Business says.</li>    <li>Moreno's interest came up at the Major League Baseball owners' meeting, Fox Business says.</li>    <li>He's said to be willing to pay around $2B for four RSNs, reportedly around the willing rate. Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color=\"red\">-1.6%</font>), forced to divest the RSNs as part of its $71B media-asset deal with Fox, had been hoping to receive $20B for the networks (an average of nearly a billion dollars for each).</li>    <li>Meanwhile, two other team owners are already <a href=\"https://seekingalpha.com/news/3430584-report-malone-enlisting-allies-battle-mlb-fox-nets\" target=\"_blank\">reportedly linked in a bid</a>: Atlanta Braves owner Liberty Media (<a href='https://seekingalpha.com/symbol/FWONA' title='Liberty Media Corp'>FWONA</a> <font color=\"red\">-0.2%</font>, <a href='https://seekingalpha.com/symbol/BATRA' title='Liberty Braves Series A'>BATRA</a> <font color=\"green\">+1.1%</font>) and Minnesota Twins owner Jim Pohlad have apparently teamed up.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431730\" data-linked=\"Fox: Angels owner may throw hat into regional sports net ring\" data-tweet=\"$FOX $FOXA $FWONA - Fox: Angels owner may throw hat into regional sports net ring https://seekingalpha.com/news/3431730-fox-angels-owner-may-throw-hat-regional-sports-net-ring?source=tweet\" data-url=\"https://seekingalpha.com/news/3431730-fox-angels-owner-may-throw-hat-regional-sports-net-ring\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431729\" data-ts=\"1549903945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431729-wedbush-warms-up-to-select-restaurant-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush warms up to select restaurant stocks</a></h4><ul><li>Analyst sentiment on restaurant stocks is generally on the rise following last week's report from Black Box Intelligence of a 2% same-store sales gain in January across a portion of the sector.</li><li>Wedbush analyst Nick Setyan lifts price targets on Denny's (<a href='https://seekingalpha.com/symbol/DENN' title='Denny&#39;s Corporation'>DENN</a> <font color='green'>+1.4%</font>)Â ($20 from $17) and Wingstop (<a href='https://seekingalpha.com/symbol/WING' title='Wingstop, Inc.'>WING</a> <font color='green'>+2%</font>) ($74 from $69), while calling DineEquity (<a href='https://seekingalpha.com/symbol/DIN' title='Dine Brands Global, Inc.'>DIN</a> <font color='green'>+3.5%</font>) the firm's favorite stock into the rash of upcoming earnings reports.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431330-restaurant-store-sales-2-percent-january\" target=\"_blank\">Restaurant same-store sales up 2% in January</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431729\" data-linked=\"Wedbush warms up to select restaurant stocks\" data-tweet=\"$DENN $WING $DIN - Wedbush warms up to select restaurant stocks https://seekingalpha.com/news/3431729-wedbush-warms-up-to-select-restaurant-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3431729-wedbush-warms-up-to-select-restaurant-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431728\" data-ts=\"1549903812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCCO\" target=\"_blank\">SCCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431728-peru-authorities-probe-possible-tailings-dam-spill-southern-copper-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peru authorities probe possible tailings dam spill at Southern Copper mine</a></h4><ul><li>Peru\u2019s environmental watchdog says it is <a href=\"http://www.mining.com/peruvian-authorities-looking-possible-tailings-dam-spill-southern-coppers-cuajone-mine/\" target=\"_blank\">investigating a potential tailings spill</a> from Southern Copper's (<a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color='red'>-2%</font>) Cuajone mine into a river in an area that has been inundated by heavy rains.</li><li>The authority says it detected a \"flow of a greenish solution\" starting Friday into the nearby Torata River in the waste deposit area of the operation; the spill apparently stopped yesterday.</li><li>SCCO says it shut down the processing plant at Cuajone as a preventative measure on Friday but  believes there was no tailings spill.</li><li>Some areas in northern Chile have suffered the <a href=\"https://www.reuters.com/article/us-peru-copper/perus-environmental-watchdog-reports-tailings-spill-from-southern-copper-mine-idUSKCN1PZ0OE\" target=\"_blank\">highest levels of rainfall in 40-plus years</a>, leaving six people dead, and neighboring Chile, the world's top copper producer, also has suspended some copper operations due to unusual rainfall.</li><li>If a spill at Cuajone actually occurred, SCCO could see renewed opposition to its $1.4B Tia Maria project, which has been stalled for years amid communities' concerns over the potential impact on water and air quality.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431728\" data-linked=\"Peru authorities probe possible tailings dam spill at Southern Copper mine\" data-tweet=\"$SCCO - Peru authorities probe possible tailings dam spill at Southern Copper mine https://seekingalpha.com/news/3431728-peru-authorities-probe-possible-tailings-dam-spill-southern-copper-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3431728-peru-authorities-probe-possible-tailings-dam-spill-southern-copper-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431724\" data-ts=\"1549903052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCJ\" target=\"_blank\">CCJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431724-cameco-says-improved-uranium-market-not-enough-to-warrant-new-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cameco says improved uranium market not enough to warrant new supply</a></h4><ul><li>Cameco (<a href='https://seekingalpha.com/symbol/CCJ' title='Cameco Corporation'>CCJ</a> <font color=\"green\">+0.3%</font>) <a href=\"http://www.miningweekly.com/article/uranium-market-improvements-not-enough-to-warrant-new-supply-cameco-2019-02-11\" target=\"_blank\">warns against investing in new uranium mines</a>, saying \"even the promise\" of new supply could create a headwind and place downward pressure on uranium prices.</li><li>\"There is plenty of idle tier one production and tier one expansion capabilities, as well as idle tier two production and expansion capabilities,\" CCJ says. \"And we can't lose sight of material sitting with financial players. This is capacity that can come back to the market relatively quickly. As a result, new supply poses a significant risk to the uranium market recovery.\"</li><li>CCJ says interest in long-term contracting has returned, but prices and contracting opportunities are not where they should be to restart idled capacity or warrant investment in growth opportunities.</li><li>The company also says the possibility of Section 232 U.S. tariffs on uranium imports is still creating uncertainty.</li><li>Shares are slightly higher after reporting better than expected <a href=\"https://seekingalpha.com/news/3431480-cameco-beats-c-0_28\" target=\"_blank\">Q4 earnings</a> while saying 2019 gross margin could come in weaker.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431724\" data-linked=\"Cameco says improved uranium market not enough to warrant new supply\" data-tweet=\"$CCJ - Cameco says improved uranium market not enough to warrant new supply https://seekingalpha.com/news/3431724-cameco-says-improved-uranium-market-not-enough-to-warrant-new-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3431724-cameco-says-improved-uranium-market-not-enough-to-warrant-new-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431723\" data-ts=\"1549903022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSC\" target=\"_blank\">NSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431723-norfolk-southernplus-4-after-updating-financial-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Norfolk Southern +4% after updating financial targets</a></h4><ul> <li>Norfolk Southern (<a href='https://seekingalpha.com/symbol/NSC' title='Norfolk Southern Corporation'>NSC</a> <font color=\"green\">+4.5%</font>) says it will unveil a strategic plan focused on increased productivity, efficiency, and revenue growth during a presentation today at an analyst conference today,</li><li>The company is targeting an operating ratio of 60% by 2021.</li> <li>Other financial targets: Full year operating ratio improvement in 2019 of at least 100 bps on the 2018 operating ratio of 65.4%; revenue growth at a compound annual rate of 5% through 2021, capital expenditures between 16% and 18%Â of revenues through 2021; dividend payout ratio of 33% and continuance of share repurchases using free cash flow and borrowing capacity.</li><li>\"Our strategic plan capitalizes on the strength of our exceptional franchise to lower costs, operate more efficiently, and deliver stronger margins,\" says CEO James Squires.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17407761-norfolk-southern-announces-strategic-plan-targeting-60-percent-operating-ratio-investor\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3431723\" data-linked=\"Norfolk Southern +4% after updating financial targets\" data-tweet=\"$NSC - Norfolk Southern +4% after updating financial targets https://seekingalpha.com/news/3431723-norfolk-southernplus-4-after-updating-financial-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3431723-norfolk-southernplus-4-after-updating-financial-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431722\" data-ts=\"1549902893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431722-rokuminus-4_6-vertical-goes-negative-on-tv-dissatisfaction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku -4.6% as Vertical goes Negative on TV dissatisfaction</a></h4><ul>   <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) is dropping again, <font color=\"red\">down 4.6%</font>, as Vertical Group cuts to Negative from Mixed on what it says is growing disappointment from television purchasers.</li>    <li>\"TV buyers\u2019 initial enthusiasm for Roku is turning to dissatisfaction as premium inventory gains fail to materialize at sufficient scale, and promises of future impressions remain tentative,\" the firm says. (h/t Bloomberg)</li>    <li>The stock's seen heavy day-to-day moves over the past month on a variety of small catalysts, including <a href=\"https://seekingalpha.com/news/3420992-roku-plus-10-percent-notes-accounts-40-percent-streaming-68-percent\" target=\"_blank\">operating updates</a>, a <a href=\"https://seekingalpha.com/news/3421426-roku-reverses-gains-minus-5_8-percent-citron-says-story-changed\" target=\"_blank\">Citron Research take</a> (and <a href=\"https://seekingalpha.com/news/3421518-roku-pares-losses-citron-clarifies-earlier-stance\" target=\"_blank\">quick clarification</a>), news from <a href=\"https://seekingalpha.com/news/3422158-roku-minus-2_5-percent-following-amazon-free-streaming-news\" target=\"_blank\">Amazon</a> and <a href=\"https://seekingalpha.com/news/3423980-roku-jumps-walmart-backs-streaming-plans\" target=\"_blank\">Walmart</a> on streaming plans, and conflicting information about <a href=\"https://seekingalpha.com/news/3429341-roku-pares-heavy-gains-comcast-disputes-bestappletv-story\" target=\"_blank\">Comcast's own streaming approach</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431722\" data-linked=\"Roku -4.6% as Vertical goes Negative on TV dissatisfaction\" data-tweet=\"$ROKU - Roku -4.6% as Vertical goes Negative on TV dissatisfaction https://seekingalpha.com/news/3431722-rokuminus-4_6-vertical-goes-negative-on-tv-dissatisfaction?source=tweet\" data-url=\"https://seekingalpha.com/news/3431722-rokuminus-4_6-vertical-goes-negative-on-tv-dissatisfaction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431714\" data-ts=\"1549902055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCRA\" target=\"_blank\">VCRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431714-vocera-down-7-chardan-cuts-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vocera down 7% as Chardan cuts to Neutral</a></h4><ul>   <li>Vocera Communications (NYSE:<a href='https://seekingalpha.com/symbol/VCRA' title='Vocera Communications'>VCRA</a>) is sliding for a second day since earnings, <font color=\"red\">down 7%</font>, amid a downgrade from Chardan to Neutral.</li>    <li>The firm cut Vocera from Buy and slashed its price target to $33 from $46, now implying 9.7% upside from today's lower pricing. Most covering firms are still Buy-rated on the stock, however.</li>    <li>The stock is <font color=\"red\">down 22.3%</font> in the past month.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431388-vocera-minus-19_7-percent-amid-weak-guidance-analyst-cuts\" target=\"_blank\">Vocera -19.7% amid weak guidance, analyst cuts</a> (Feb. 08 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431714\" data-linked=\"Vocera down 7% as Chardan cuts to Neutral\" data-tweet=\"$VCRA - Vocera down 7% as Chardan cuts to Neutral https://seekingalpha.com/news/3431714-vocera-down-7-chardan-cuts-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3431714-vocera-down-7-chardan-cuts-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431713\" data-ts=\"1549901889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431713-crude-oil-slumps-on-stronger-dollar-u-s-china-worries-rising-u-s-rig-count\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil slumps on stronger dollar, U.S.-China worries, rising U.S. rig count</a></h4><ul><li><a href=\"https://www.wsj.com/articles/oil-prices-pause-to-start-the-week-11549883074\" target=\"_blank\">Crude oil prices slide near four-week lows</a> due to a stronger dollar and continued concerns about U.S.-China trade talks; WTI <font color=\"red\">-2.1%</font> to $51.59/bbl, Brent <font color=\"red\">-1.3%</font> at $61.31/bbl.</li><li>Despite the drop in crude, the Energy Select SPDR (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='green'>+0.1%</font>) is posting a small gain; <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color=\"red\">-2.4%</font>.</li><li>\"The U.S. dollar is strengthening again today in spurring much of today\u2019s early WTI weakness,\" according to analysts at Ritterbusch and Associates. \"WTI appeared much more willing to follow equities lower than higher last week with the strength in the U.S. dollar evolving as the decider in pushing WTI values back to below our expected $53 support.\"</li><li>\"Oil prices are still <a href=\"https://www.reuters.com/article/us-global-oil/oil-prices-slide-slow-progress-in-trade-talks-counters-opec-cuts-idUSKCN1Q0013\" target=\"_blank\">trying to figure out what lead to follow</a>,\" says Vienna-based consultancy JBC Energy. \"On the one hand, there is the OPEC+ cut story, now coupled with increasing issues around Venezuelan supply. [But] it has to be argued that a lot of the economic data that has been  released over the last few days has really not been too encouraging, and  U.S.-Chinese trade talks are also seemingly not progressing very fast.\"</li><li>Also, the U.S. oil rig count <a href=\"https://seekingalpha.com/news/3431423-u-s-oil-rig-count-gains-7-baker-hughes-survey-says\" target=\"_blank\">jumped last week</a> and there are \"rumors that Venezuela is trying to <a href=\"https://www.marketwatch.com/story/oil-prices-slip-as-us-rig-count-rises-again-2019-02-11\" target=\"_blank\">skirt U.S. sanctions</a> by means of trade with India,\" says RJOÂ Futures senior market strategist John Caruso. \"More downside in coming weeks is our forecast,\" but with WTI likely holding the $49-$48 area.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3431713\" data-linked=\"Crude oil slumps on stronger dollar, U.S.-China worries, rising U.S. rig count\" data-tweet=\"$USO $XLE $OIL - Crude oil slumps on stronger dollar, U.S.-China worries, rising U.S. rig count https://seekingalpha.com/news/3431713-crude-oil-slumps-on-stronger-dollar-u-s-china-worries-rising-u-s-rig-count?source=tweet\" data-url=\"https://seekingalpha.com/news/3431713-crude-oil-slumps-on-stronger-dollar-u-s-china-worries-rising-u-s-rig-count\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431712\" data-ts=\"1549901782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAP\" target=\"_blank\">BAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431712-credicorp-down-2_5-baml-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credicorp down 2.5% as BAML downgrades</a></h4><ul><li>A perky valuation combined with slowing economic growth in Peru and higher expenses isn't a good combination, says BAML, downgrading Credicorp (<a href='https://seekingalpha.com/symbol/BAP' title='Credicorp, Ltd.'>BAP</a> <font color='red'>-2.7%</font>) to Underperform.</li><li>The $231 price target compares to the current $233.49.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431712\" data-linked=\"Credicorp down 2.5% as BAML downgrades\" data-tweet=\"$BAP - Credicorp down 2.5% as BAML downgrades https://seekingalpha.com/news/3431712-credicorp-down-2_5-baml-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3431712-credicorp-down-2_5-baml-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431711\" data-ts=\"1549901766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431711-hertz-and-avis-in-rally-mode\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz and Avis in rally mode</a></h4><ul> <li>Avis Budget (<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a> <font color=\"green\">+7.1%</font>) is holding on to its premarket gain as investors size up Goldman Sachs' two-notch upgrade on the car rental stock.</li><li>\"We believe valuation looks attractive for mean reversion \u2014 currently trading at 6.2x our 2019E EBITDA estimate vs. a historical trough multiple of 5.9x and long-term average 8.4x \u2014 as most of the headwinds the industry (and the company) is facing appear priced in,\" writes GS analyst David Tamberrino.</li><li>Hertz Global (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color=\"green\">+6.5%</font>) is also on the move after the Avis upgrade. Of course, huge swings in Hertz are nothing new amid a long vs short battle that's been playing out for more than a year. Short interest on Hertz was reported at 25% on January 25.</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3431600-avis-budget-plus-6-percent-two-notch-upgrade-goldman-sachs\" target=\"_blank\">Avis Budget +6% after two-notch upgrade from Goldman Sachs</a> (Feb. 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431711\" data-linked=\"Hertz and Avis in rally mode\" data-tweet=\"$CAR $HTZ - Hertz and Avis in rally mode https://seekingalpha.com/news/3431711-hertz-and-avis-in-rally-mode?source=tweet\" data-url=\"https://seekingalpha.com/news/3431711-hertz-and-avis-in-rally-mode\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431706\" data-ts=\"1549901077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431706-nuvasive-and-ohr-pharmaceutical-among-healthcare-gainers-celldex-therapeutics-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuVasive and OHR Pharmaceutical among healthcare gainers; Celldex Therapeutics leads the losers</a></h4><ul><li><b>Gainers:Â </b>Nemaura Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a>) <font color=\"green\">+29%</font>. Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a>) <font color=\"green\">+19%</font>. Replimune Group (NASDAQ:<a href='https://seekingalpha.com/symbol/REPL' title='Replimune Group'>REPL</a>) <font color=\"green\">+18%</font>. NuVasive (NASDAQ:<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a>) <font color=\"green\">+16%</font>. OHR Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a>) <font color=\"green\">+12%</font>.</li><li><b>Losers:Â </b>Celldex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a>) <font color=\"red\">-15%</font>. Mustang Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MBIO' title='Mustang Bio, Inc.'>MBIO</a>) <font color=\"red\">-12%</font>. Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"red\">-10%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-9%</font>. NantKwest (NASDAQ:<a href='https://seekingalpha.com/symbol/NK' title='NantKwest'>NK</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431706\" data-linked=\"NuVasive and OHR Pharmaceutical among healthcare gainers; Celldex Therapeutics leads the losers\" data-tweet=\"$NMRD $PTI $REPL - NuVasive and OHR Pharmaceutical among healthcare gainers; Celldex Therapeutics leads the losers https://seekingalpha.com/news/3431706-nuvasive-and-ohr-pharmaceutical-among-healthcare-gainers-celldex-therapeutics-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431706-nuvasive-and-ohr-pharmaceutical-among-healthcare-gainers-celldex-therapeutics-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431704\" data-ts=\"1549900768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431704-keybanc-raises-workdays-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc raises Workday&#39;s target</a></h4><ul><li>KeyBanc maintains an Overweight rating on Workday (NYSE:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a>) and raises the target from $179 to $216.</li><li>Workday is expected to report earnings on February 28. Consensus <a href=\"https://seekingalpha.com/symbol/WDAY/earnings\" target=\"_blank\">estimates</a> have revenue at $776.5M with $0.32 EPS.</li><li>Workday shares areÂ <font color=\"green\">up 0.8%</font>Â to $190.92.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431704\" data-linked=\"KeyBanc raises Workday&#39;s target\" data-tweet=\"$WDAY - KeyBanc raises Workday&#39;s target https://seekingalpha.com/news/3431704-keybanc-raises-workdays-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3431704-keybanc-raises-workdays-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431703\" data-ts=\"1549900753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USX\" target=\"_blank\">USX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431703-post-earnings-rally-extends-for-u-s-xpress\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rally extends for U.S. Xpress</a></h4><ul> <li>Shares of U.S. Xpress Enterprises (<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises'>USX</a> <font color='green'>+7.4%</font>) break back over $9 for the first time since last November as the post-earnings rally continues.</li><li>The company reported operating income of $21.1M inQ4vs. compared to $12.5M a year ago.</li> <li>USX is up 16% over the last two sessions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431102-u-s-xpress-beats-0_03-beats-revenue\" target=\"_blank\">U.S. Xpress beats by $0.03, beats on revenue</a> (Feb. 7)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3431703\" data-linked=\"Post-earnings rally extends for U.S. Xpress\" data-tweet=\"$USX - Post-earnings rally extends for U.S. Xpress https://seekingalpha.com/news/3431703-post-earnings-rally-extends-for-u-s-xpress?source=tweet\" data-url=\"https://seekingalpha.com/news/3431703-post-earnings-rally-extends-for-u-s-xpress\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431698\" data-ts=\"1549900163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRC\" target=\"_blank\">RRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431698-range-resourcesplus-4-after-impressive-reserve-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Range Resources +4% after &#39;impressive&#39; reserve update</a></h4><ul><li>Range Resources (<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='green'>+4.6%</font>) rallies as much as 5.5% intraday after what Scotia Howard Weil calls \"another strong year\" of <a href=\"https://seekingalpha.com/news/3431653-range-resources-says-proved-reserves-rose-18-percent-year-end-2018\" target=\"_blank\">proved reserve growth at 18%</a> to 18.1T cfe.</li><li>RRC says it added a record 3.1T cfe to its proved reserves from extensions, discoveries and additions, driven by its Marcellus Shale inventory.</li><li>Drill-bit finding costs were an \"impressive\" $0.22/Mcfe, which Scotia Howard Weil analyst Holly Stewart says were well below last year and below the three-year average of ~$0.45/Mcfe; the firm rates RRC at Outperform with a $17 price target (source:Â Bloomberg First Word).</li><li>RRC says year-end 2018 proved reserves by volume were 67% natural gas, 30%  natural gas liquids and 3% crude oil and condensate; proved developed reserves represent 54% of the company\u2019s reserves.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431698\" data-linked=\"Range Resources +4% after &#39;impressive&#39; reserve update\" data-tweet=\"$RRC - Range Resources +4% after &#39;impressive&#39; reserve update https://seekingalpha.com/news/3431698-range-resourcesplus-4-after-impressive-reserve-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3431698-range-resourcesplus-4-after-impressive-reserve-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431697\" data-ts=\"1549900146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431697-vanda-selloff-continues-shares-down-6-on-bearish-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda selloff continues, shares down 6% on bearish report</a></h4><ul><li>Buyers of Vanda Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a> <font color=\"red\">-5.5%</font>)Â continue to be a scarce commodity. Shares are have slumped over <font color=\"red\">40%</font> since late January.</li><li>Last week, the company sued the FDA in an effort to force it to lift the <a href=\"https://seekingalpha.com/news/3430111-vanda-pharma-sues-fda-partial-clinical-hold-tradipitant-shares-12-percent-premarket\" target=\"_blank\">partial clinical hold</a> on tradipitant.</li><li>Today, Aurelius Value published a <a href=\"http://www.aureliusvalue.com/research/vanda-in-the-land-of-the-blind-the-one-eyed-man-is-king/\" target=\"_blank\">bearish report</a> citing a whistleblower <a href=\"http://aureliusvalue.com/content/uploads/2019/02/USA-vs-Vanda.pdf\" target=\"_blank\">lawsuit </a>claiming that the company continues to violate the False Claims Act via fraudulent billing to the U.S. government, off-label marketing and illegal marketing tactics related to Fanapt and Hetlioz.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431697\" data-linked=\"Vanda selloff continues, shares down 6% on bearish report\" data-tweet=\"$VNDA - Vanda selloff continues, shares down 6% on bearish report https://seekingalpha.com/news/3431697-vanda-selloff-continues-shares-down-6-on-bearish-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3431697-vanda-selloff-continues-shares-down-6-on-bearish-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431692\" data-ts=\"1549899642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPAA\" target=\"_blank\">MPAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431692-motorcar-parts-of-america-down-7-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Motorcar Parts of America down 7% post Q3 results</a></h4><ul><li>Motorcar Parts of America (<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a> <font color=\"red\">-7.6%</font>) reported Q3 net sales growth of 20.6% Y/Y to $124.1M, reflecting increases in the rotating electrical business; and Adj. net sales growth of 14.4% Y/Y to $119.63M.</li><li>Q3 Gross marginÂ <font color=\"red\">declined by 830 bps</font>Â to 17.1%; and operating marginÂ <font color=\"red\">declined by 687 bpsÂ </font>to 1.31%.</li><li>Adj. gross marginÂ <font color=\"red\">declined by 358 bps</font>Â to 25.8%, margin was impacted by higher freight and wage costs, higher returns, the introduction of electric vehicle test systems, overtime and other costs related to the increase in new business.</li><li>Adj. EBITDA was $16.19M (-5.9% Y/Y) and marginÂ <font color=\"red\">declined by 368 bps</font>Â to 13%.</li><li>Q3 Expenses: G&amp;A $12.33M (+3.5% Y/Y); Sales &amp; Marketing $5.15M (+17.2% Y/Y); and R&amp;D $2.05M (+22.4% Y/Y).</li><li>Company has Cash and cash equivalents of $8.59M, as of December 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431588-motorcar-parts-america-misses-0_03-beats-revenue\" target=\"_blank\">Motorcar Parts of America misses by $0.03, beats on revenue</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431692\" data-linked=\"Motorcar Parts of America down 7% post Q3 results\" data-tweet=\"$MPAA - Motorcar Parts of America down 7% post Q3 results https://seekingalpha.com/news/3431692-motorcar-parts-of-america-down-7-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3431692-motorcar-parts-of-america-down-7-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431689\" data-ts=\"1549899136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNA\" target=\"_blank\">CNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431689-cna-sinks-8_3-cat-losses-lower-investment-return-drives-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNA sinks 8.3% as cat losses, lower investment return drives Q4 loss</a></h4><ul><li>CNA Financial (NYSE:<a href='https://seekingalpha.com/symbol/CNA' title='CNA Financial Corporation'>CNA</a>)<font color=\"red\"> drops 8.3%</font>Â after <a href=\"https://seekingalpha.com/pr/17407262-cna-financial-announces-fourth-quarter-2018-resultshttps://seekingalpha.com/pr/17407262-cna-financial-announces-fourth-quarter-2018-results\" target=\"_blank\">Q4 core results</a> swung to a loss on increased catastrophe losses and lower investment returns.</li><li>Q4 core loss per share of 8 cents compares with core income per share of $1.05 in the year-ago period; the catastrophe losses and investment returns from its limited partnership and common equities accounted for 82 cents of the per-share loss.</li><li>Book value per share excluding AOCI of $44.55 at Dec. 31, 2018 declined from $45.02 at Dec. 31, 2017.</li><li>Q4 net catastrophe losses were $146M vs. $38M in the year-ago quarter.</li><li>Q4 Property &amp; Casualty net written premiums of $1.66B increased 4% from $1.60B a year ago.</li><li>Q4 P&amp;C net investment income of $127M fell from $305M a year ago.</li><li>Q4 P&amp;C underlying combined ratio of 98.0% vs. 95.8% a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431535-cna-financial-eps-0_08\" target=\"_blank\">CNA Financial EPS of -$0.08</a> (Feb. 11)</li><li>Related ticker: <a href='https://seekingalpha.com/symbol/L' title='Loews Corporation'>L</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3431689\" data-linked=\"CNA sinks 8.3% as cat losses, lower investment return drives Q4 loss\" data-tweet=\"$CNA $L - CNA sinks 8.3% as cat losses, lower investment return drives Q4 loss https://seekingalpha.com/news/3431689-cna-sinks-8_3-cat-losses-lower-investment-return-drives-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3431689-cna-sinks-8_3-cat-losses-lower-investment-return-drives-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431687\" data-ts=\"1549899024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431687-salesforceplus-2-on-new-health-cloud-tools\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce +2% on new Health Cloud tools</a></h4><ul><li>Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) <a href=\"https://seekingalpha.com/pr/17407457-salesforce-delivers-new-health-cloud-innovations-personalize-patient-experiences-improve\" target=\"_blank\">unveils</a> a new Health Cloud tool called Social Determinants of Health that helps hospitals and insurance spot environmental issues that could impact a patient's health, like income or a lack of transportation.</li><li>The company also debuts Field Service Lightning to unite collaborating health care organizations onto one HIPAA-compliant platform. The tool can connect dispatchers, home health nurses, and other providers for a more efficient treatment process.</li><li>The Social Determinants tool comes free with a Health Cloud subscription, but Field Service requires an additional license.</li><li>Salesforce shares are<font color=\"green\">Â up 2.1%</font>Â to $159.91.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431687\" data-linked=\"Salesforce +2% on new Health Cloud tools\" data-tweet=\"$CRM - Salesforce +2% on new Health Cloud tools https://seekingalpha.com/news/3431687-salesforceplus-2-on-new-health-cloud-tools?source=tweet\" data-url=\"https://seekingalpha.com/news/3431687-salesforceplus-2-on-new-health-cloud-tools\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431685\" data-ts=\"1549898852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBGI\" target=\"_blank\">BBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431685-beasley-broadcastplus-5-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beasley Broadcast +5% post Q4 results</a></h4><div><ul><li>Radio broadcaster Beasley Broadcast Group (<a href='https://seekingalpha.com/symbol/BBGI' title='Beasley Broadcast Group, Inc.'>BBGI</a> <font color=\"green\">+4.9%</font>) isÂ 4.9% upÂ after revenue estimate beat showing <a href=\"https://seekingalpha.com/pr/17407330-beasley-broadcast-group-2018-fourth-quarter-net-revenue-rises-29_1-percent-75_6-million\" target=\"_blank\">double-digit</a> revenue gains of 29.1% Y/Y.</li><li>Operating income fell to $13.9M from $23.3M, decrease reflects a net benefit of $13.9M in Q4 2017 related to change in fair value of contingent consideration and gain on exchange in connection with the acquisition of Greater Media.</li><li>Station operating income (a non-GAAP measure) rose to $20.6M, reflects the net revenue growth which more than offset a 26.3% Y/Y rise in station operating expenses related to the Company\u2019s expanded platform.</li><li>Net income dropped to $2.1M from $69.7M, solely because of gains and tax benefits in the year-ago period that did not recur in the Q4 2018.</li><li>Q4 FCF increased 33.9%, to $8.6M over the same period in 2017.</li><li>\u201cOur record Q4 and FY revenue and strong operating results, despite the benefit of non-cash transaction related and tax items in the 2017 period, highlight the value being created as we execute strategies to expand our scale, diversify our revenue mix and leverage the value of our local brands in our core and ancillary verticals.\" says CEO Caroline Beasley.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431560-beasley-broadcast-eps-0_08\" target=\"_blank\">Beasley Broadcast EPS of $0.08</a> (Feb. 11)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3431685\" data-linked=\"Beasley Broadcast +5% post Q4 results\" data-tweet=\"$BBGI - Beasley Broadcast +5% post Q4 results https://seekingalpha.com/news/3431685-beasley-broadcastplus-5-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3431685-beasley-broadcastplus-5-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431683\" data-ts=\"1549898361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGL\" target=\"_blank\">NGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431683-ngl-energy-partnersplus-7-after-big-quarterly-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NGL Energy Partners +7% after big quarterly beat</a></h4><ul><li>NGLÂ Energy Partners (<a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a> <font color='green'>+7.1%</font>) shoots higher after routing expectations for <a href=\"https://seekingalpha.com/news/3431550-ngl-energy-partners-beats-0_57-beats-revenue\" target=\"_blank\">FQ3 earnings</a> and revenues, which jumped 47% Y/Y to $6.4B.</li><li>NGL reports adjusted EBITDA for the quarter was $132.6M vs. $122.6M for the year-ago quarter, and it reaffirms guidance for full-year adjusted EBITDA of $450M.</li><li>NGL says adjusted EBITDA jumped 67% Y/Y in its crude oil logistics segment to $50.7M, rose 14% in its refined products and renewables group to $10.5M, climbed 35% in its liquids segment to $27M, and added 38% in its water solutions business to $48.2M.</li><li>\"Our compliance       leverage is below our 3.25x target while our distribution coverage is       improving and we expect will continue to do so,\" the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431683\" data-linked=\"NGL Energy Partners +7% after big quarterly beat\" data-tweet=\"$NGL - NGL Energy Partners +7% after big quarterly beat https://seekingalpha.com/news/3431683-ngl-energy-partnersplus-7-after-big-quarterly-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3431683-ngl-energy-partnersplus-7-after-big-quarterly-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431677\" data-ts=\"1549897790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOGO\" target=\"_blank\">SOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431677-sogouminus-1_5-on-deutsche-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sogou -1.5% on Deutsche downgrade</a></h4><ul><li>Deutsche Bank downgrades Sogou (NYSE:<a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a>) ADRs from Hold to Sell.</li><li>Earlier this month, Sogou<a href=\"https://seekingalpha.com/news/3428556-sogou-reports-mixed-q4\" target=\"_blank\"> reported</a> Q4 results that missed revenue estimates and included downside Q1 revenue guidance.</li><li>SOGO shares areÂ <font color=\"red\">down 1.5%</font>Â to $5.98.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431677\" data-linked=\"Sogou -1.5% on Deutsche downgrade\" data-tweet=\"$SOGO - Sogou -1.5% on Deutsche downgrade https://seekingalpha.com/news/3431677-sogouminus-1_5-on-deutsche-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3431677-sogouminus-1_5-on-deutsche-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431671\" data-ts=\"1549897391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCY\" target=\"_blank\">MCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431671-mercury-generalminus-5_2-wildfires-fuel-q4-operating-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercury General -5.2% as wildfires fuel Q4 operating loss</a></h4><ul><li>Mercury General (NYSE:<a href='https://seekingalpha.com/symbol/MCY' title='Mercury General Corporation'>MCY</a>)<font color=\"red\"> slumps 5.2%</font>Â after <a href=\"https://seekingalpha.com/pr/17407627-mercury-general-corporation-announces-fourth-quarter-fiscal-2018-results-declares-quarterly\" target=\"_blank\">Q4 operating loss</a> of $14.6M, or 26 cents per share, as California wildfires increased catastrophe losses during the quarter.</li><li>Compares with operating income of $8.5M, or 15 cents per share, a year ago.</li><li>Q4 catastrophe losses net of reinsurance more than doubled to $43.0M from $20.0M in the year-ago quarter.</li><li>Catastrophe losses before reinsurance benefits ballooned to $255M from $109M in the year-earlier period, primarily due to the California wildfires.</li><li>Q4 combined ratio rose to 106.7% from 104.5%.</li><li>Q4 net premiums earned increased 7.6% to $868.2M from $806.8M a year ago.</li><li>Q4 net premiums written rose 9.2% to $850.6M from $779.2M.</li><li>Book value per share fell to $29.23 at Dec. 31, 2018 vs. $31.83 at Dec. 31, 2017.</li><li><a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2370673-1&amp;h=369046169&amp;u=http%3A%2F%2Fwww.mercuryinsurance.com%2F&amp;a=www.mercuryinsurance.com\" target=\"_blank\">Conference call</a> at 1:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431612-mercury-general-eps-0_26\" target=\"_blank\">Mercury General EPS of -$0.26</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431671\" data-linked=\"Mercury General -5.2% as wildfires fuel Q4 operating loss\" data-tweet=\"$MCY - Mercury General -5.2% as wildfires fuel Q4 operating loss https://seekingalpha.com/news/3431671-mercury-generalminus-5_2-wildfires-fuel-q4-operating-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3431671-mercury-generalminus-5_2-wildfires-fuel-q4-operating-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431661\" data-ts=\"1549896493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSP\" target=\"_blank\">NSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431661-insperity-shoots-12-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insperity shoots 12% post Q4 results</a></h4><div><ul><li>Insperity (<a href='https://seekingalpha.com/symbol/NSP' title='Insperity, Inc.'>NSP</a> <font color=\"green\">+12.1%</font>) reports revenues rose 17% Y/Y inÂ <a href=\"https://seekingalpha.com/pr/17407321-insperity-announces-record-fourth-quarter-full-year-2018-results\" target=\"_blank\">Q4</a> to $966.8M, on 17% increase in the average number of worksite employees paid/ month.</li><li>Average WSEEs paid were 221,809 (+17% Y/Y).</li><li>Gross margin rateÂ <font color=\"red\">declined 58 bps</font>Â to 16.71%.</li><li>Operating margin rateÂ <font color=\"green\">up 50 bps</font>Â to 3.37%.</li><li>Adj. EBITDAÂ <font color=\"green\">increased 26 bps</font>Â to 4.92%.</li><li>Share repurchases totaled 0.99M shares at a cost of $97.1M.</li><li>Adj. cash, equivalents and marketable securities at Dec. 31, 2018 was $128.9M.</li><li>Adj. EBITDA per WSEE per month increased 17% to $95 in 2018.</li><li>\u201cThese results reflect our 4th year in a row with growth in adj. EBITDA above 25%, increasing from $84M to $240M demonstrating effective execution of our strategic plan.\u201d saidÂ Paul J. Sarvadi, Insperity chairman and CEO.</li><li><b>Q1 Guidance</b>: Average WSEEs 224-226K; Adj. EBITDA: $96-99M (+15%-18%) Adj. EPS: $1.85-1.91 (+31%-35%).</li><li><b>FY2019 Guidance</b>: Average WSEEs 234.4-242.6K; Adj. EBITDA: $268-285M (+12%-19%) Adj. EPS: $4.37-4.69 (+17%-25%).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431557-insperity-beats-0_04-beats-revenue\" target=\"_blank\">Insperity beats by $0.04, beats on revenue</a> (Feb. 11)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3431661\" data-linked=\"Insperity shoots 12% post Q4 results\" data-tweet=\"$NSP - Insperity shoots 12% post Q4 results https://seekingalpha.com/news/3431661-insperity-shoots-12-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3431661-insperity-shoots-12-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431659\" data-ts=\"1549895974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431659-tsmc-remains-apples-exclusive-series-supplier-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSMC remains Apple&#39;s exclusive A-series supplier - report</a></h4><ul><li>TSMC (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) <a href=\"https://9to5mac.com/2019/02/10/digitimes-7nm-a13-2019-iphone/\" target=\"_blank\">will remain</a> the exclusive supplier for Apple's A-series chips with the 7nm A13 debuting this year, according to Digitimes sources.</li><li>Volume production will ramp up in Q2.</li><li>TSMC shares are<font color=\"green\"> up 0.8%</font>Â to $38.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431659\" data-linked=\"TSMC remains Apple&#39;s exclusive A-series supplier - report\" data-tweet=\"$TSM - TSMC remains Apple&#39;s exclusive A-series supplier - report https://seekingalpha.com/news/3431659-tsmc-remains-apples-exclusive-series-supplier-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3431659-tsmc-remains-apples-exclusive-series-supplier-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431657\" data-ts=\"1549895765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431657-bed-bath-beyondminus-3-after-loop-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond -3% after Loop cut</a></h4><ul> <li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) opens<font color=\"red\"> down 2.85%</font> after the retailer is lowered to a Sell rating by the analyst team at Loop Capital.</li> <li>Loop warns that Bed Bath &amp; Beyond will fall short of hitting its full-year guidance.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3421904-bed-bath-and-beyond-plus-21-percent-positive-outlook\" target=\"_blank\">Bed Bath &amp; Beyond +21% after positive outlook</a> (Jan. 9)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3431657\" data-linked=\"Bed Bath &amp; Beyond -3% after Loop cut\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond -3% after Loop cut https://seekingalpha.com/news/3431657-bed-bath-beyondminus-3-after-loop-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3431657-bed-bath-beyondminus-3-after-loop-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431651\" data-ts=\"1549895215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431651-nuva-and-ngl-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NUVA and NGL among premarket gainers</a></h4><ul><li>Avalon GloboCare (<a href='https://seekingalpha.com/symbol/AVCO' title='Avalon GloboCare Corp.'>OTCQB:AVCO</a>) <font color=\"green\">+23%</font>Â on <a href=\"https://seekingalpha.com/pr/17407649-avalon-globocare-announces-breakthrough-identifying-human-angiogenic-exosomes-extracellular\" target=\"_blank\">announcing</a> breakthrough in identifying human angiogenic exosomes/extracellular vesicles.</li><li>NuVasive (NASDAQ:<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a>)Â <font color=\"green\">+14%</font>Â on <a href=\"https://seekingalpha.com/news/3431624-smith-and-nephew-nuvasive-go-opposite-ways-potential-tie\" target=\"_blank\">merger</a> talks with SNN.</li><li>Camtek (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a>)Â <font color=\"green\">+10%</font>Â on Chroma <a href=\"https://seekingalpha.com/news/3431618-chroma-buys-20_5-percent-camtek-camt-plus-10-percent\" target=\"_blank\">acquiring</a> 20.5% shares.</li><li>Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>) <font color=\"green\">+9%</font>Â on <a href=\"https://seekingalpha.com/pr/17407405-avenue-therapeutics-announces-first-stage-closing-acquisition-agreement-invagen-cipla\" target=\"_blank\">announcing</a> first stage closing of its acquisition agreement with InvaGen.</li><li>NGL Energy Partners LP (NYSE:<a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a>)Â <font color=\"green\">+8%</font>. on <a href=\"https://seekingalpha.com/news/3431550-ngl-energy-partners-beats-0_57-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Proteon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTO' title='Proteon Therapeutics'>PRTO</a>) <font color=\"green\">+6%</font>.</li><li>Alphatec Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a>) <font color=\"green\">+8%</font>.</li><li>Avis Budget Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a>)Â <font color=\"green\">+7%</font>Â after two-notch <a href=\"https://seekingalpha.com/news/3431600-avis-budget-plus-6-percent-two-notch-upgrade-goldman-sachs\" target=\"_blank\">upgrade</a> from Goldman Sachs.</li><li>Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <font color=\"green\">+7%</font>Â on <a href=\"https://seekingalpha.com/pr/17407651-inpixon-announces-ibm-maas360-watson-integration-enable-enhanced-location-based-mobile-device\" target=\"_blank\">announcing</a> IBM MaaS360 with Watson Integration.</li><li>Northstar Realty Europe (NYSE:<a href='https://seekingalpha.com/symbol/NRE' title='NorthStar Realty Europe Corp.'>NRE</a>) <font color=\"green\">+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431651\" data-linked=\"NUVA and NGL among premarket gainers\" data-tweet=\"$AVCO $NUVA $CAMT - NUVA and NGL among premarket gainers https://seekingalpha.com/news/3431651-nuva-and-ngl-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431651-nuva-and-ngl-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431650\" data-ts=\"1549895173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNY\" target=\"_blank\">CLNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431650-colony-capitalplus-1_2-after-pact-activist-forms-review-committee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colony Capital +1.2% after pact with activist, forms review committee</a></h4><ul><li>Colony Capital (NYSE:<a href='https://seekingalpha.com/symbol/CLNY' title='Colony Capital, Inc.'>CLNY</a>)<font color=\"green\"> gains 1.2%</font>Â in premarket trading after <a href=\"https://seekingalpha.com/pr/17407735-colony-capital-inc-announces-corporate-governance-enhancements\" target=\"_blank\">entering a cooperation agreement</a> with Blackwells Capital.</li><li>Appoints Raymond MikulichÂ andÂ Craig Hatkoff to the board, effective immediately.</li><li>Blackwells and Colony will jointly agree on an additional appointment to the board.</li><li>Board forms a strategic asset review committee to review, evaluate, and make recommendations to the board on issues relating to the company's assets and business configuration.</li><li>Blackwells has agreed to certain customary standstill provisions, including voting in favor of the company's proposed slate of directors at Colony's 2019 annual meeting.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3431637-colony-capital-3_5-percent-activist-interest\" target=\"_blank\">Colony Capital up 3.5% on activist interest</a> (Feb. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3431650\" data-linked=\"Colony Capital +1.2% after pact with activist, forms review committee\" data-tweet=\"$CLNY - Colony Capital +1.2% after pact with activist, forms review committee https://seekingalpha.com/news/3431650-colony-capitalplus-1_2-after-pact-activist-forms-review-committee?source=tweet\" data-url=\"https://seekingalpha.com/news/3431650-colony-capitalplus-1_2-after-pact-activist-forms-review-committee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431648\" data-ts=\"1549895047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDX\" target=\"_blank\">CLDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431648-post-reverse-split-trading-in-celldex-commences-today-shares-down-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-reverse split trading in Celldex commences today; shares down 12% premarket</a></h4><ul><li>Aimed at regaining compliance with Nasdaq's $1M minimum bid price listing requirement, Celldex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a>) has <a href=\"https://seekingalpha.com/pr/17406802-celldex-therapeutics-announces-reverse-stock-split\" target=\"_blank\">executed </a>a 1:15 reverse split of its common shares. Post-split trading commences today.</li><li>Shares are down <font color=\"red\">12%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431648\" data-linked=\"Post-reverse split trading in Celldex commences today; shares down 12% premarket\" data-tweet=\"$CLDX - Post-reverse split trading in Celldex commences today; shares down 12% premarket https://seekingalpha.com/news/3431648-post-reverse-split-trading-in-celldex-commences-today-shares-down-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3431648-post-reverse-split-trading-in-celldex-commences-today-shares-down-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431647\" data-ts=\"1549894948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431647-goodyear-tire-rubber-under-pressure-after-analysts-chip-away\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp; Rubber under pressure after analysts chip away</a></h4><ul> <li>Argus lowers Goodyear Tire &amp; Rubber (NASDAQ:<a href='https://seekingalpha.com/symbol/GT' title='The Goodyear Tire & Rubber Company'>GT</a>) to a Hold rating from Buy.</li> <li>\"Goodyear recently posted weak 4Q18 results, missing the consensus estimates on both revenue and EPS. We are also concerned about the impact of rising raw material costs on 2019 earnings,\" warns Argus analyst David Coleman. The firm assigns a lower trading multiple on Goodyear due to the expectation for higher input costs.</li> <li>Also in the mix, Longbow Research drops Goodyear to an Underperform rating from Neutral and Goldman Sachs (Sell, $17 PT) warns on a \"tough year\" for the tire seller.</li> <li>Shares of Goodyear are <font color=\"red\">down 1.28%</font> in premarket trading to $18.45.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431647\" data-linked=\"Goodyear Tire &amp; Rubber under pressure after analysts chip away\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber under pressure after analysts chip away https://seekingalpha.com/news/3431647-goodyear-tire-rubber-under-pressure-after-analysts-chip-away?source=tweet\" data-url=\"https://seekingalpha.com/news/3431647-goodyear-tire-rubber-under-pressure-after-analysts-chip-away\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431645\" data-ts=\"1549894762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYX\" target=\"_blank\">AYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431645-alteryxminus-2-on-wedbush-sideline-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alteryx -2% on Wedbush sideline move</a></h4><ul><li>Wedbush downgrades Alteryx (NYSE:<a href='https://seekingalpha.com/symbol/AYX' title='Alteryx'>AYX</a>) from Outperform to Neutral saying valuation \"isn't enticing\" after the recent rally put shares near the $72 price target.</li><li>The firm also cites Alteryx's move into predictive analytics where its prospects \"look uncertain.\" But Wedbush sees sufficient near-term momentum and says AYX has \"plenty of room to beat and guide up.\"</li><li>AYX shares have gainedÂ <font color=\"green\">nearly 32%</font>Â in the past quarter and areÂ <font color=\"red\">down 2%</font>Â premarket to $68.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3431645\" data-linked=\"Alteryx -2% on Wedbush sideline move\" data-tweet=\"$AYX - Alteryx -2% on Wedbush sideline move https://seekingalpha.com/news/3431645-alteryxminus-2-on-wedbush-sideline-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3431645-alteryxminus-2-on-wedbush-sideline-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3431642\" data-ts=\"1549894520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3431642-avya-and-snn-among-premaket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVYA and SNN among premaket losers</a></h4><ul><li>Celldex Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a>) <font color=\"red\">-11%</font>.</li><li>Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"red\">-12%</font>.</li><li>Avaya Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AVYA' title='Avaya Holdings Corp.'>AVYA</a>)Â <font color=\"red\">-6%</font>Â on <a href=\"https://seekingalpha.com/news/3431570-avaya-holdings-misses-revenue\" target=\"_blank\">Q1 results</a>.</li><li>Smith &amp; Nephew (NYSE:<a href='https://seekingalpha.com/symbol/SNN' title='Smith & Nephew plc'>SNN</a>)Â <font color=\"red\">-5%</font>Â on <a href=\"https://seekingalpha.com/news/3431624-smith-and-nephew-nuvasive-go-opposite-ways-potential-tie\" target=\"_blank\">merger</a> talks with NuVasive.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3431642\" data-linked=\"AVYA and SNN among premaket losers\" data-tweet=\"$CLDX $EYEN $AVYA - AVYA and SNN among premaket losers https://seekingalpha.com/news/3431642-avya-and-snn-among-premaket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3431642-avya-and-snn-among-premaket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}